Cholan-24-oic acid, 3,7-dihydroxy-, sodium salt (1:1), (3α,5β,7β)-
| Title | Journal |
|---|---|
| UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats. | Toxicology and applied pharmacology 20161115 |
| Obeticholic Acid: First Global Approval. | Drugs 20160801 |
| Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations. | Molecular neurobiology 20160301 |
| Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins. | Experimental biology and medicine (Maywood, N.J.) 20150201 |
| New enzymatic assay for the AKR1C enzymes. | Chemico-biological interactions 20130225 |
| Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes. | PloS one 20130101 |
| Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress. | Journal of cellular and molecular medicine 20121101 |
| N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice. | Journal of gastroenterology and hepatology 20121101 |
| Ursodeoxycholic acid for nonalcoholic steatohepatitis. | European journal of gastroenterology & hepatology 20121101 |
| Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis. | The Journal of biological chemistry 20121019 |
| Ursodeoxycholic acid for cystic fibrosis-related liver disease. | The Cochrane database of systematic reviews 20121017 |
| Ursodeoxycholic acid in patients with chronic heart failure. | Journal of the American College of Cardiology 20121016 |
| Specific bile acids inhibit hepatic fatty acid uptake in mice. | Hepatology (Baltimore, Md.) 20121001 |
| Ursodeoxycholic acid stimulates the formation of the bile canalicular network. | Biochemical pharmacology 20121001 |
| Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. | Oncology reports 20121001 |
| Hepatoprotective efficacy of ursodeoxycholic acid in pediatrics acute lymphoblastic leukemia. | Pediatric hematology and oncology 20121001 |
| Formation of tubules by p-tert-butylphenylamide derivatives of chenodeoxycholic and ursodeoxycholic acids in aqueous solution. | Steroids 20121001 |
| Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. | The American journal of surgical pathology 20121001 |
| Sarcoidosis of the liver: to treat or not to treat? | The Netherlands journal of medicine 20121001 |
| The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. | European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20120901 |
| Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. | Scandinavian journal of gastroenterology 20120901 |
| Novel whole-cell biocatalysts with recombinant hydroxysteroid dehydrogenases for the asymmetric reduction of dehydrocholic acid. | Applied microbiology and biotechnology 20120901 |
| Therapeutic approach of hepatic sarcoidosis. | Current opinion in pulmonary medicine 20120901 |
| Molecular targets for the treatment of fibrosing cholangiopathies. | Clinical pharmacology and therapeutics 20120901 |
| Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity. | Surgery 20120901 |
| Ursodeoxycholic acid: increased mortality. | Prescrire international 20120901 |
| Urosdeoxycholic acid in primary sclerosing cholangitis: a meta-analysis and systematic review. | Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20120901 |
| Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP. | Basic & clinical pharmacology & toxicology 20120801 |
| Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations. | Journal of pediatric gastroenterology and nutrition 20120801 |
| Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats. | Diabetes research and clinical practice 20120801 |
| Common bile duct stones in infancy: a medical approach. | Journal of paediatrics and child health 20120801 |
| Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study. | Alimentary pharmacology & therapeutics 20120801 |
| Synergistic mechanism of gene expression and pathways between jasminoidin and ursodeoxycholic acid in treating focal cerebral ischemia-reperfusion injury. | CNS neuroscience & therapeutics 20120801 |
| The effect of ursodesoxycholic acid on duodenal adenomas in familial adenomatous polyposis: a prospective randomized placebo-control trial. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20120701 |
| Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | Metabolism: clinical and experimental 20120701 |
| Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study. | Liver international : official journal of the International Association for the Study of the Liver 20120701 |
| Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health. | Journal of hepatology 20120701 |
| How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation? | Experimental hematology 20120701 |
| The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. | European journal of gastroenterology & hepatology 20120701 |
| Recent insights in primary sclerosing cholangitis. | Journal of digestive diseases 20120701 |
| UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation. | International journal of cancer 20120615 |
| Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. | Neuropharmacology 20120601 |
| Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. | Acta pharmacologica Sinica 20120601 |
| Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20120601 |
| Primary sclerosing cholangitis and interstitial nephropathy: an emerging association? | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514 |
| Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20120501 |
| Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. | Hepatology (Baltimore, Md.) 20120501 |
| Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. | Journal of gastroenterology 20120501 |
| Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice. | American journal of physiology. Gastrointestinal and liver physiology 20120501 |
| Nonalcoholic fatty liver disease. | Clinics in liver disease 20120501 |
| Management of primary sclerosing cholangitis: conventions and controversies. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20120501 |
| Traditional Chinese medicine: China's bear farms prompt public outcry. | Nature 20120425 |
| Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system. | Molecular pharmaceutics 20120402 |
| Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. | Clinics and research in hepatology and gastroenterology 20120401 |
| Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRα. | Journal of lipid research 20120401 |
| Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases. | Scandinavian journal of gastroenterology 20120401 |
| Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20120401 |
| Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. | Journal of digestive diseases 20120401 |
| Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20120401 |
| [Intrahepatic cholestasis of pregnancy: review]. | Ginecologia y obstetricia de Mexico 20120401 |
| High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. | World journal of gastroenterology 20120307 |
| Diagnostic and therapeutic challenges in pediatric primary sclerosing cholangitis. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120301 |
| Ursodeoxycholic acid in primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20120301 |
| New fluorescent bile acids: synthesis, chemical characterization, and disastereoselective uptake by Caco-2 cells of 3-deoxy 3-NBD-amino deoxycholic and ursodeoxycholic acid. | Bioorganic & medicinal chemistry 20120301 |
| Intrahepatic cholestasis of pregnancy: a case report. | Connecticut medicine 20120301 |
| Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells. | Toxicology 20120226 |
| Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. | Journal of the American College of Cardiology 20120207 |
| Bile salts for the treatment of heart failure: out on a limb for a gut feeling? | Journal of the American College of Cardiology 20120207 |
| A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities. | Journal of perinatology : official journal of the California Perinatal Association 20120201 |
| Comparison of different bile acid-phospholipid conjugates in acute hepatitis. | European journal of clinical investigation 20120201 |
| Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. | Hepatology (Baltimore, Md.) 20120201 |
| Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis. | Cancer prevention research (Philadelphia, Pa.) 20120201 |
| Primary sclerosing cholangitis: is any treatment worthwhile? | Current gastroenterology reports 20120201 |
| Bile acid-cysteamine conjugates: structural properties, gelation, and toxicity evaluation. | Steroids 20120201 |
| Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20120201 |
| High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. | Alimentary pharmacology & therapeutics 20120201 |
| Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial. | Journal of Korean medical science 20120201 |
| Bezafibrate for primary biliary cirrhosis. | The Cochrane database of systematic reviews 20120118 |
| Serum lipids in primary sclerosing cholangitis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120101 |
| Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. | Gastroenterology 20120101 |
| Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients. | Chinese journal of integrative medicine 20120101 |
| Ursodeoxycholic acid prevents selenite-induced oxidative stress and alleviates cataract formation: In vitro and in vivo studies. | Molecular vision 20120101 |
| [Obesity and gallbladder diseases]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120101 |
| Wilson's disease--treatment of psychiatric manifestations in pregnancy. | Psychosomatics 20120101 |
| Don't hold the salt when working up dermatoses of pregnancy. | Cutis 20120101 |
| Amoxicillin/clavulanic acid-induced cholestatic liver injury after pediatric liver transplantation. | Annals of transplantation 20120101 |
| Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. | Nutrition and cancer 20120101 |
| Perinatal cytomegalovirus hepatitis in Saudi infants: a case series. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101 |
| Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. | BMJ (Clinical research ed.) 20120101 |
| A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis. | Internal medicine (Tokyo, Japan) 20120101 |
| [A case report of Byler's syndrome]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20120101 |
| [Principles and perspectives of primary biliary cirrhosis therapy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20120101 |
| Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block. | PloS one 20120101 |
| Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature. | Diagnostic pathology 20120101 |
| [Interstitial lung disease in patients with primary biliary cirrhosis]. | Pneumonologia i alergologia polska 20120101 |
| Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. | International journal of molecular sciences 20120101 |
| Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications: a randomized clinical trial. | Digestion 20120101 |
| Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans. | Digestion 20120101 |
| [Primary biliary cirrhosis (PBC)]. | Duodecim; laaketieteellinen aikakauskirja 20120101 |
| [Specific features of hypolipidemic therapy in patients with abdominal ischemic disease]. | Terapevticheskii arkhiv 20120101 |
| Physicochemical characterization and toxicity evaluation of steroid-based surfactants designed for solubilization of poorly soluble drugs. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111218 |
| The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis. | Fundamental & clinical pharmacology 20111201 |
| Ursodeoxycholic acid promotes intestinal adaptation in a cat model of short bowel syndrome. | Fundamental & clinical pharmacology 20111201 |
| In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. | Digestive diseases and sciences 20111201 |
| A major step towards effective treatment evaluation in primary biliary cirrhosis. | Journal of hepatology 20111201 |
| Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. | Journal of hepatology 20111201 |
| Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. | Clinical science (London, England : 1979) 20111201 |
| Combined treatment strategies for unconjugated hyperbilirubinemia in Gunn rats. | Pediatric research 20111201 |
| Effect of ursodeoxycholic acid supplementation on growth, carcass characteristics, and meat quality of Wagyu heifers (Japanese Black cattle). | Journal of animal science 20111201 |
| Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients. | Clinical biochemistry 20111201 |
| A placental phenotype for intrahepatic cholestasis of pregnancy. | Placenta 20111201 |
| Prurigo nodularis as the first manifestation of a chronic autoimmune cholestatic hepatitis. | International journal of dermatology 20111201 |
| Medical and endoscopic therapy of primary sclerosing cholangitis. | Best practice & research. Clinical gastroenterology 20111201 |
| Percutaneous management of bile-plug syndrome: a case report. | Journal of pediatric surgery 20111201 |
| Administration of ursodeoxycholate failed to prevent sludge and/or gallstone formation in cholecystokinin-1(A) receptor-deficient mice. | Biomedical research (Tokyo, Japan) 20111201 |
| Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20111201 |
| [Three schistosomiasis patients combined with acute hepatitis E]. | Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control 20111201 |
| [Emergency check list: acute biliary colic]. | MMW Fortschritte der Medizin 20111103 |
| Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. | NMR in biomedicine 20111101 |
| No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid. | European journal of clinical pharmacology 20111101 |
| Regioselective oxidation of cholic acid and its 7β epimer by using o-iodoxybenzoic acid. | Steroids 20111101 |
| High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20111101 |
| Medical therapy for primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20111101 |
| Long-term virological follow up of patients with occult hepatitis C virus infection. | Liver international : official journal of the International Association for the Study of the Liver 20111101 |
| Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. | Gastroenterology 20111001 |
| Cholestatic hepatitis related to amoxicillin. | Drug and chemical toxicology 20111001 |
| Labial salivary gland biopsy in the investigation of neonatal hemochromatosis. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20111001 |
| A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart. | Hepatology (Baltimore, Md.) 20111001 |
| Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20111001 |
| Primary bile acid therapy during pregnancy in patients with 3β-hydroxy-Δ5 -C27 -steroid oxidoreductase deficiency. | Pediatrics international : official journal of the Japan Pediatric Society 20111001 |
| A contemporary analysis of parenteral nutrition-associated liver disease in surgical infants. | Journal of pediatric surgery 20111001 |
| Scratching can reveal more than just an itch. | The practising midwife 20111001 |
| Hormonal contraception after intrahepatic cholestasis of pregnancy. | Ceska gynekologie 20111001 |
| Fusion of core pathways reveals a horizontal synergistic mechanism underlying combination therapy. | European journal of pharmacology 20110930 |
| [Cetirizine hepatotoxicity]. | Medicina clinica 20110910 |
| Do fatigue and UDCA therapy truly have independent effects on mortality in PBC? | Journal of hepatology 20110901 |
| Cholesterol-derived bile acids enhance the chaperone activity of α-crystallins. | Cell stress & chaperones 20110901 |
| Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid. | Journal of gastroenterology and hepatology 20110901 |
| High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. | The American journal of gastroenterology 20110901 |
| Present status of autoimmune hepatitis in Japan: a nationwide survey. | Journal of gastroenterology 20110901 |
| Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110901 |
| Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus. | Liver international : official journal of the International Association for the Study of the Liver 20110901 |
| No more pilots, a phase III trial of fibrates in primary biliary cirrhosis is long overdue! | Journal of gastroenterology and hepatology 20110901 |
| The diagnosis and treatment of primary biliary cirrhosis. | The Korean journal of hepatology 20110901 |
| Varices in early histological stage primary biliary cirrhosis. | Journal of clinical gastroenterology 20110801 |
| Pregnancy in primary sclerosing cholangitis. | Gut 20110801 |
| Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110801 |
| Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. | American journal of physiology. Gastrointestinal and liver physiology 20110801 |
| The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view. | Liver international : official journal of the International Association for the Study of the Liver 20110801 |
| Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? | Best practice & research. Clinical gastroenterology 20110801 |
| [No complaints, but constantly elevated cholestatic serum liver tests]. | Praxis 20110706 |
| A case of recovery from canine destructive cholangitis in a Miniature Dachshund. | The Journal of veterinary medical science 20110701 |
| Is the addition of choleretic agents in multiple double-pigtail biliary stents effective for difficult common bile duct stones in elderly patients? A prospective, multicenter study. | Gastrointestinal endoscopy 20110701 |
| Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. | Scandinavian journal of gastroenterology 20110601 |
| Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth. | Oncology reports 20110601 |
| Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. | Alimentary pharmacology & therapeutics 20110601 |
| Prolonged cholestasis due to hepatitis A virus infection. | Indian pediatrics 20110601 |
| The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice. | European journal of pharmacology 20110520 |
| New therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reports. | American journal of therapeutics 20110501 |
| Effects of ursodeoxycholic acid in esophageal motility and the role of the mucosa. An experimental study. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110501 |
| UDCA for NASH: end of the story? | Journal of hepatology 20110501 |
| A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. | Journal of hepatology 20110501 |
| Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. | Carcinogenesis 20110501 |
| Blueberry muffin rash, hyperbilirubinemia, and hypoglycemia: a case of hemolytic disease of the fetus and newborn due to anti-Kp(a). | Journal of perinatology : official journal of the California Perinatal Association 20110501 |
| Ulcerative colitis and an abnormal cholangiogram. | Cleveland Clinic journal of medicine 20110501 |
| Massive hydrops of the gallbladder mimicking a choledochal cyst. | Journal of pediatric surgery 20110501 |
| [Observation on therapeutic alliance with UDCA and glucocorticoids in AIH-PBC overlap syndrome]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110501 |
| [Pay more attention to standardizing the diagnosis and treatment of intrahepatic cholestasis of pregnancy]. | Zhonghua fu chan ke za zhi 20110501 |
| [Alternative therapies for hepatitis C: UDCA and SNMC]. | Nihon rinsho. Japanese journal of clinical medicine 20110501 |
| Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats. | European journal of pharmacology 20110425 |
| Reduced resting potentials in dystrophic (mdx) muscle fibers are secondary to NF-κB-dependent negative modulation of ouabain sensitive Na+-K+ pump activity. | Journal of the neurological sciences 20110415 |
| The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury. | Journal of hepatology 20110401 |
| Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. | Journal of gastroenterology and hepatology 20110401 |
| Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. | British journal of pharmacology 20110401 |
| Identification, cloning, heterologous expression, and characterization of a NADPH-dependent 7β-hydroxysteroid dehydrogenase from Collinsella aerofaciens. | Applied microbiology and biotechnology 20110401 |
| Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110401 |
| Delayed postnatal presentation of biliary atresia in 2 premature neonates. | Journal of pediatric gastroenterology and nutrition 20110401 |
| Successful use of ursodeoxycholic acid in nodular regenerative hyperplasia of the liver. | The Annals of pharmacotherapy 20110401 |
| Inhibitory effects of bile acids on enzymatic and pharmacological activities of a snake venom phospholipase A(2) from group IIA. | The protein journal 20110401 |
| Novel developments in IBD-related sclerosing cholangitis. | Best practice & research. Clinical gastroenterology 20110401 |
| A validated RP-HPLC method for quantitative determination of related impurities of ursodeoxycholic acid (API) by refractive index detection. | Journal of pharmaceutical and biomedical analysis 20110325 |
| Secondary sclerosing cholangitis following major burn injury-An underestimated issue in burn care? | Burns : journal of the International Society for Burn Injuries 20110301 |
| A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. | Liver international : official journal of the International Association for the Study of the Liver 20110301 |
| Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. | Gut 20110301 |
| Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20110301 |
| Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection. | European journal of gastroenterology & hepatology 20110301 |
| Microlithiasis, endoscopic ultrasound, and children: not just little gallstones in little adults. | Journal of pediatric surgery 20110301 |
| Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis triggered by fluvastatin. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20110301 |
| Small-duct sclerosing cholangitis associated with Schistosoma mansoni. | Hepatology (Baltimore, Md.) 20110201 |
| Physical-chemical parameters and validation of a colorimetric method for deoxycholic and ursodeoxycholic acids: kit reagent and optical sensor. | Chemistry and physics of lipids 20110201 |
| Primary dermatologic findings with early-onset intrahepatic cholestasis of pregnancy. | Obstetrics and gynecology 20110201 |
| Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells. | Hepatology (Baltimore, Md.) 20110201 |
| Bile acids for primary sclerosing cholangitis. | The Cochrane database of systematic reviews 20110119 |
| Screening for novel antibacterial agents based on the activities of compounds on metabolism of Escherichia coli: a microcalorimetric study. | Journal of hazardous materials 20110115 |
| Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators. | Journal of medicinal chemistry 20110113 |
| The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis. | Clinics and research in hepatology and gastroenterology 20110101 |
| Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. | Alimentary pharmacology & therapeutics 20110101 |
| Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. | Journal of pediatric gastroenterology and nutrition 20110101 |
| Evaluation of the pharmacokinetic interaction of midazolam with ursodeoxycholic acid, ketoconazole and dexamethasone by brain benzodiazepine receptor occupancy. | The Journal of pharmacy and pharmacology 20110101 |
| The influence of passive stretch and NF-κB inhibitors on the morphology of dystrophic muscle fibers. | Anatomical record (Hoboken, N.J. : 2007) 20110101 |
| Effects of chemical modification of ursodeoxycholic acid on TGR5 activation. | Biological & pharmaceutical bulletin 20110101 |
| Risk factors and prediction of long-term outcome in primary biliary cirrhosis. | Internal medicine (Tokyo, Japan) 20110101 |
| [Fatty liver and its clinical management in obese adolescents]. | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110101 |
| Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury. | Digestion 20110101 |
| A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus. | Internal medicine (Tokyo, Japan) 20110101 |
| [Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid]. | Ginekologia polska 20110101 |
| [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver]. | Terapevticheskii arkhiv 20110101 |
| [Successful cytolytic at three months child with gallstone disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [Intrahepatic cholestasis in chronic liver diseases]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery. | Internal medicine (Tokyo, Japan) 20110101 |
| Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates. | Digestive diseases (Basel, Switzerland) 20110101 |
| Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients. | Digestive diseases (Basel, Switzerland) 20110101 |
| [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation]. | Annales de dermatologie et de venereologie 20110101 |
| [Cytoprotective effect of ursodeoxycholic acid on the gastroduodenal zone mucous membrane at elderly patients with a combination of gallstone disease and duodenal ulcer]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| Two-year experience of obstetric cholestasis: outcome and management. | Clinical and experimental obstetrics & gynecology 20110101 |
| Estimation of recurrence of colorectal adenomas with dependent censoring using weighted logistic regression. | PloS one 20110101 |
| Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat. | PloS one 20110101 |
| [Significance of biliary dysfunction in the pathogenesis of gallstone disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [Biliary pancreatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [UDCA in the treatment of nonalcoholic fatty liver disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [The substantiation of UDCA usage in functional disorders of biliary tract]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [UDCA in the treatment of nonalcoholic fatty liver disease]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [3rd place in the competition of scientific work in hepatology in 2010. Treatment of patients with overlap of primary biliary cirrhosis and autoimmune hepatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| Discriminant analysis using a multivariate linear mixed model with a normal mixture in the random effects distribution. | Statistics in medicine 20101230 |
| Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid. | International journal of pharmaceutics 20101215 |
| [Gastroenterology and hepatology. Using established therapies]. | MMW Fortschritte der Medizin 20101202 |
| Corticosteroid therapy in a case of severe cholestasic hepatitis associated with amoxicillin-clavulanate. | Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201 |
| Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101201 |
| [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis]. | Yao xue xue bao = Acta pharmaceutica Sinica 20101201 |
| Biliary stones: an atypical cause of abdominal pain in paediatric age group. | JPMA. The Journal of the Pakistan Medical Association 20101201 |
| Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. | European journal of gastroenterology & hepatology 20101201 |
| Application of near infrared spectroscopy for rapid analysis of intermediates of Tanreqing injection. | Journal of pharmaceutical and biomedical analysis 20101102 |
| Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid. | Digestive diseases and sciences 20101101 |
| The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up. | Journal of hepatology 20101101 |
| The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up. | Journal of hepatology 20101101 |
| Pathogenesis of cholestatic liver disease and therapeutic approaches. | Gastroenterology 20101101 |
| Methotrexate for primary biliary cirrhosis: who is to be trusted? | Digestive diseases and sciences 20101101 |
| Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. | Hepatology (Baltimore, Md.) 20101101 |
| Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. | The American journal of gastroenterology 20101001 |
| Ursodeoxycholic acid and chemoprevention of colorectal cancer. | Gastroenterologie clinique et biologique 20101001 |
| Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. | American journal of physiology. Gastrointestinal and liver physiology 20101001 |
| Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53. | Biochemical and biophysical research communications 20101001 |
| Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. | Best practice & research. Clinical gastroenterology 20101001 |
| Cystic fibrosis-associated liver disease. | Best practice & research. Clinical gastroenterology 20101001 |
| Primary biliary cirrhosis. | Best practice & research. Clinical gastroenterology 20101001 |
| Primary sclerosing cholangitis. | Best practice & research. Clinical gastroenterology 20101001 |
| [A two-year follow-up study on the efficacy of ursodeoxycholic acid on primary biliary cirrhosis in different stages]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20101001 |
| Herbal hepatotoxicity: a case of difficult interpretation. | European review for medical and pharmacological sciences 20101001 |
| A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. | Journal of controlled release : official journal of the Controlled Release Society 20100915 |
| Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children. | Pediatric transplantation 20100901 |
| Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20100901 |
| Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. | Cancer research 20100901 |
| A concentration-dependent effect of ursodeoxycholate on apoptosis and caspases activities of HepG2 hepatocellular carcinoma cells. | European journal of pharmacology 20100825 |
| The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature. | Digestive diseases and sciences 20100801 |
| Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution. | Pediatric transplantation 20100801 |
| Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. | Antioxidants & redox signaling 20100801 |
| Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100801 |
| In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival. | Journal of hepatology 20100801 |
| Treatment options for primary sclerosing cholangitis. | Expert review of gastroenterology & hepatology 20100801 |
| High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. | Hepatology (Baltimore, Md.) 20100801 |
| Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. | Hepatology (Baltimore, Md.) 20100801 |
| Risk of biliary complications in bariatric surgery. | Journal of visceral surgery 20100801 |
| 3β-hydroxy-Δ⁵-C₂₇-steroid dehydrogenase/isomerase deficiency in a patient who underwent oral bile acid therapy for 10 years and delivered two healthy infants. | Pediatrics international : official journal of the Japan Pediatric Society 20100801 |
| Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. | Journal of the neurological sciences 20100715 |
| Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. | European journal of gastroenterology & hepatology 20100701 |
| Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. | Hepatology (Baltimore, Md.) 20100701 |
| [Alagille syndrome diagnosed in adolescence: a case report]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20100701 |
| Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis. | The Journal of the Association of Physicians of India 20100701 |
| No evidence of direct binding between ursodeoxycholic acid and the p53 DNA-binding domain. | Bioscience reports 20100603 |
| Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100601 |
| Rapid quantification of conjugated and unconjugated bile acids and C27 precursors in dried blood spots and small volumes of serum. | Journal of lipid research 20100601 |
| Update on primary sclerosing cholangitis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100601 |
| Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase/isomerase deficiency. | Journal of pediatric gastroenterology and nutrition 20100601 |
| The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy. | Cardiovascular toxicology 20100601 |
| Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601 |
| Pharmacotherapy of cholestatic liver diseases. | Journal of digestive diseases 20100601 |
| [Prognosis of Korean patients with primary biliary cirrhosis]. | The Korean journal of hepatology 20100601 |
| [Clinical features and prognosis of primary biliary cirrhosis in Korea]. | The Korean journal of hepatology 20100601 |
| [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. | Voenno-meditsinskii zhurnal 20100601 |
| Management of gallstones and gallbladder disease in patients undergoing gastric bypass. | World journal of gastroenterology 20100507 |
| NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study. | The American journal of gastroenterology 20100501 |
| ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. | Hepatology (Baltimore, Md.) 20100501 |
| Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction. | Pediatric surgery international 20100501 |
| The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. | Seminars in liver disease 20100501 |
| [Good prognosis in asymptomatic primary biliary cirrhosis]. | Lakartidningen 20100501 |
| Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. | International journal of cancer 20100401 |
| [Pruritus associated with cholestasis]. | Gastroenterologia y hepatologia 20100401 |
| Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells. | Carcinogenesis 20100401 |
| Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice. | Hepatology (Baltimore, Md.) 20100401 |
| Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. | Journal of hepatology 20100401 |
| [Importance of bile acids for intra-hepatic cholestasis of pregnancy]. | Gynecologie, obstetrique & fertilite 20100401 |
| Biliary physiology and disease: reflections of a physician-scientist. | Hepatology (Baltimore, Md.) 20100401 |
| [Usefulness of ursodeoxycholic acid in a case of hepatic sarciodosis]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100401 |
| Bile acids are multifunctional modulators of the Barrett's carcinogenesis. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100401 |
| Bile acids for liver-transplanted patients. | The Cochrane database of systematic reviews 20100317 |
| Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C. | Journal of gastroenterology 20100301 |
| Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis? | Translational research : the journal of laboratory and clinical medicine 20100301 |
| Cholelithiasis in a neonate with chylous ascites. | Journal of perinatology : official journal of the California Perinatal Association 20100301 |
| Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy? | The American journal of gastroenterology 20100301 |
| Successful treatment of primary Sjögren's syndrome complicated with primary biliary cirrhosis and lung involvement. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301 |
| Understanding of chemoprophylaxis and concordance in inflammatory bowel disease. | World journal of gastroenterology 20100207 |
| Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. | Digestive diseases and sciences 20100201 |
| Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100201 |
| Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. | Journal of gastroenterology and hepatology 20100201 |
| Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice. | Journal of gastroenterology and hepatology 20100201 |
| Liver disease associated with canalicular transport defects: current and future therapies. | Journal of hepatology 20100201 |
| Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. | Expert opinion on pharmacotherapy 20100201 |
| Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC? | Nature reviews. Gastroenterology & hepatology 20100201 |
| The role of p53 in apoptosis. | Discovery medicine 20100201 |
| [Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20100201 |
| [Influence of pharmacological treatment on selected parameters of intrahepatic cholestasis of pregnancy]. | Ginekologia polska 20100201 |
| [The characteristics of peripheral lymphocytic subsets and cytokines in primary biliary and their changes to drug treatment.]. | Zhonghua nei ke za zhi 20100201 |
| By the way, doctor. I have read that people who have had their gallbladders removed should take bile salts. My gallbladder was removed many years ago, and no doctor has said I should take bile salts. Should I? | Harvard health letter 20100201 |
| Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis. | Current gastroenterology reports 20100201 |
| Learning from the pregnane X receptor: how to fight one aggressor with two strategies. | Liver international : official journal of the International Association for the Study of the Liver 20100201 |
| Non-surgical management of idiopathic fibrosing pancreatitis. | European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie 20100101 |
| High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. | JPEN. Journal of parenteral and enteral nutrition 20100101 |
| Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid. | Journal of neurochemistry 20100101 |
| Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid. | Journal of clinical gastroenterology 20100101 |
| Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. | Clinical neuropharmacology 20100101 |
| Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. | Journal of pediatric surgery 20100101 |
| Atorvastatin-induced prolonged cholestasis with bile duct damage. | Clinical drug investigation 20100101 |
| NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. | Lipids in health and disease 20100101 |
| Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. | Gastroenterologie clinique et biologique 20100101 |
| Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward. | Gastroenterologie clinique et biologique 20100101 |
| Targeting the p53 pathway of apoptosis. | Current pharmaceutical design 20100101 |
| Lightbulbs of the biliary tree: A radiological finding in Christmas time. | Annals of hepatology 20100101 |
| The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults. | Gastroenterologie clinique et biologique 20100101 |
| Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis. | Hepato-gastroenterology 20100101 |
| Acute seronegative autoimmune hepatitis. | Hepato-gastroenterology 20100101 |
| [Bile acids in norm and pathology]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| [Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. | Hepato-gastroenterology 20100101 |
| Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. | PloS one 20100101 |
| Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. | BMC gastroenterology 20100101 |
| Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases. | International journal of immunopathology and pharmacology 20100101 |
| [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report. | The Journal of reproductive medicine 20100101 |
| Protective effects of ursodeoxycholic acid against immune-mediated liver fibrosis in rats. | Hepato-gastroenterology 20100101 |
| [Possibility of correction of the lipid disorders in patients with cholelithiasis and gallbladder cholesterosis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| [Effect of ursodeoxycholic acid for reducing the deficit of vitamin D status and bone mineral density at gallstones]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Surgical outcome in relation to duct size at the porta hepatis and the use of cholagogues in patients with biliary atresia. | Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20100101 |
| [Drug UDCA (Ursosan) in therapeutic management of patients Barrett's esophagus]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101 |
| Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice. | Transplantation 20091227 |
| Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines. | Journal of hepatology 20091201 |
| Hepatobiliary associations with inflammatory bowel disease. | Expert review of gastroenterology & hepatology 20091201 |
| Cholelitiasis: state of the art. | Minerva gastroenterologica e dietologica 20091201 |
| Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. | Cancer prevention research (Philadelphia, Pa.) 20091201 |
| A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. | Anticancer research 20091201 |
| [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3]. | Zhonghua yi xue za zhi 20091117 |
| Cholestasis in neonatal intensive care unit: incidence, aetiology and management. | Acta paediatrica (Oslo, Norway : 1992) 20091101 |
| Pharmacologic therapy of non-alcoholic steatohepatitis. | Clinics in liver disease 20091101 |
| Simple determination of deoxycholic and ursodeoxycholic acids by phenolphthalein-beta-cyclodextrin inclusion complex. | Lipids 20091101 |
| Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis. | Journal of paediatrics and child health 20091101 |
| [The clinical characteristics of primary biliary cirrhosis in China: a systematic review]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091101 |
| Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort. | Digestive diseases and sciences 20091001 |
| Effect of biliary stenting combined with ursodeoxycholic acid and terpene treatment on retained common bile duct stones in elderly patients: a multicenter study. | The American journal of gastroenterology 20091001 |
| Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis. | International journal of colorectal disease 20091001 |
| [Right upper quadrant abdominal pain and fever. Genetic phospholipid deficiency]. | Gastroenterologie clinique et biologique 20091001 |
| [Effect of integrative Chinese and Western medicine in treating pregnant women with intrahepatic cholestasis]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20091001 |
| Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid. | Journal of infection in developing countries 20090915 |
| Autoimmune liver disease for the non-specialist. | BMJ (Clinical research ed.) 20090908 |
| Bile acids: regulation of apoptosis by ursodeoxycholic acid. | Journal of lipid research 20090901 |
| High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. | Hepatology (Baltimore, Md.) 20090901 |
| Primary biliary cirrhosis. | Seminars in immunopathology 20090901 |
| High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater? | Hepatology (Baltimore, Md.) 20090901 |
| The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20090901 |
| [Primary biliary cirrhosis: therapeutic options]. | Recenti progressi in medicina 20090901 |
| Effect of ursodeoxycholic acid treatment on the expression and function of multidrug resistance-associated protein 2 in rat intestine. | Journal of pharmaceutical sciences 20090801 |
| Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol. | Hepatology (Baltimore, Md.) 20090801 |
| Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR. | Biochimica et biophysica acta 20090801 |
| Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country. | Acta paediatrica (Oslo, Norway : 1992) 20090801 |
| Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells. | Annals of the New York Academy of Sciences 20090801 |
| Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. | Journal of hepatology 20090701 |
| Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent. | Hepatology (Baltimore, Md.) 20090701 |
| GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies? | Gut 20090701 |
| [Risk factors for recurrent bile duct stones after endoscopic clearance of common bile duct stones]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090701 |
| A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. | World journal of gastroenterology 20090614 |
| Management of autoimmune liver disease. | Minerva gastroenterologica e dietologica 20090601 |
| Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. | Hepatology (Baltimore, Md.) 20090601 |
| [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid]. | Anales de pediatria (Barcelona, Spain : 2003) 20090601 |
| The chronic liver disease in patients with short bowel syndrome: etiology and treatment. | Minerva pediatrica 20090601 |
| Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis. | Hepatology (Baltimore, Md.) 20090601 |
| Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. | Hepatology (Baltimore, Md.) 20090601 |
| Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis. | Vojnosanitetski pregled 20090601 |
| Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells. | Chinese medical journal 20090520 |
| Importance of using highly pure internal standards for successful liquid chromatography/tandem mass spectrometric bioanalytical assays. | Rapid communications in mass spectrometry : RCM 20090501 |
| Physical activity as a determinant of fecal bile acid levels. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20090501 |
| Biliary microlithiasis. | Gastrointestinal endoscopy 20090501 |
| Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. | Journal of pediatric gastroenterology and nutrition 20090501 |
| Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis. | Pathology international 20090501 |
| Management of autoimmune and cholestatic liver disorders. | Clinics in liver disease 20090501 |
| Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease. | The Veterinary clinics of North America. Small animal practice 20090501 |
| [The right medicine for cerebrotendinous xanthomatosis]. | Nederlands tijdschrift voor geneeskunde 20090411 |
| Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial. | Atherosclerosis 20090401 |
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. | Gastroenterology 20090401 |
| Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. | Gastroenterology 20090401 |
| [Hepatobiliary transport of glutathione and its role in cholestasis]. | Yao xue xue bao = Acta pharmaceutica Sinica 20090401 |
| Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells. | Biochemical pharmacology 20090301 |
| [Autoimmune liver diseases]. | Der Internist 20090301 |
| Analysis of colorectal adenoma recurrence data subject to informative censoring. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20090301 |
| Autoimmune hemolityc anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto's thyroiditis: a new entity of autoimmune polyendocrine syndrome. | Journal of endocrinological investigation 20090301 |
| Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? | Clinical reviews in allergy & immunology 20090201 |
| Paralytic ileus and liver failure--an unusual presentation of advanced erythropoietic protoporphyria. | Digestive diseases and sciences 20090201 |
| Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats. | Gastroenterology 20090201 |
| Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse. | Neuromuscular disorders : NMD 20090201 |
| A retrospective single-center review of primary sclerosing cholangitis in children. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20090201 |
| The role of membrane cholesterol in determining bile acid cytotoxicity and cytoprotection of ursodeoxycholic acid. | Biochimica et biophysica acta 20090201 |
| Effect of ursodeoxycholic acid on the pharmacokinetics of midazolam and CYP3A in the liver and intestine of rats. | Xenobiotica; the fate of foreign compounds in biological systems 20090201 |
| Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. | Clinical science (London, England : 1979) 20090101 |
| Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. | Journal of clinical gastroenterology 20090101 |
| Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20090101 |
| Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis. | Journal of hepato-biliary-pancreatic surgery 20090101 |
| Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. | Annals of clinical biochemistry 20090101 |
| A patient with primary biliary cirrhosis and elevated LDL cholesterol. | Clinical chemistry 20090101 |
| Bear bile: dilemma of traditional medicinal use and animal protection. | Journal of ethnobiology and ethnomedicine 20090101 |
| Elevated bile acids associated with acute hepatitis A infection in the third trimester of pregnancy. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20090101 |
| Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. | Journal of gastroenterology 20090101 |
| Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis. | BMC pregnancy and childbirth 20090101 |
| Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. | Annals of hepatology 20090101 |
| [Effect of praziquantel and ursodeoxycholic acid therapy on bile lithogenicity in patients with opisthorchosis on the background of main variant of standard diet]. | Voprosy pitaniia 20090101 |
| [Effect pf cholecystectomy on bile lithogenecity and morphological changes in the pancreas of patients with chronic biliary pancreatitis]. | Klinicheskaia meditsina 20090101 |
| Primary sclerosing cholangitis: a clinical case. | Digestive diseases (Basel, Switzerland) 20090101 |
| [Primary biliary cirrhosis]. | Nederlands tijdschrift voor geneeskunde 20090101 |
| [Drug (statine)-induced hepatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation. | Biochemical and biophysical research communications 20081226 |
| Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. | The Journal of biological chemistry 20081226 |
| 7alpha- and 12alpha-Hydroxysteroid dehydrogenases from Acinetobacter calcoaceticus lwoffii: a new integrated chemo-enzymatic route to ursodeoxycholic acid. | Steroids 20081222 |
| Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. | Obesity surgery 20081201 |
| Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid. | Gut 20081201 |
| Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. | Pediatrics 20081201 |
| Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations. | Minerva gastroenterologica e dietologica 20081201 |
| Apoptotic signaling pathways as a target for the treatment of liver diseases. | Mini reviews in medicinal chemistry 20081201 |
| Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment. | Journal of gastrointestinal and liver diseases : JGLD 20081201 |
| Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus. | World journal of gastroenterology 20081114 |
| Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. | Gastroenterology 20081101 |
| Portal hypertension in primary biliary cirrhosis: a potentially reversible harbinger of demise. | Gastroenterology 20081101 |
| Chemoprevention of colorectal cancer: feasibility in everyday practice? | European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20081101 |
| Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children. | Journal of pediatric gastroenterology and nutrition 20081101 |
| Current and emerging therapies in nonalcoholic fatty liver disease. | Seminars in liver disease 20081101 |
| Imaging induction of cytoprotective enzymes in intact human cells: coumberone, a metabolic reporter for human AKR1C enzymes reveals activation by panaxytriol, an active component of red ginseng. | Journal of the American Chemical Society 20081029 |
| [Incidentally diagnosed stones of the gallbladder]. | MMW Fortschritte der Medizin 20081023 |
| Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy. | Toxicology and applied pharmacology 20081015 |
| Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. | American journal of physiology. Gastrointestinal and liver physiology 20081001 |
| [Liver diseases in pregnancy]. | Deutsche medizinische Wochenschrift (1946) 20081001 |
| Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient. | World journal of gastroenterology 20080907 |
| Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20080901 |
| [A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20080901 |
| Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. | European journal of clinical investigation 20080901 |
| Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. | Liver international : official journal of the International Association for the Study of the Liver 20080801 |
| Hepatic nuclear factor 1alpha inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin. | Drug metabolism and disposition: the biological fate of chemicals 20080801 |
| Cholestatic liver disease in long-term infantile nephropathic cystinosis. | Journal of gastroenterology and hepatology 20080801 |
| Primary sclerosing cholangitis. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080801 |
| Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. | Swiss medical weekly 20080726 |
| Ursodeoxycholic acid for primary biliary cirrhosis. | The Cochrane database of systematic reviews 20080716 |
| [Non-alcoholic fatty liver disease and cardiovascular risk]. | Orvosi hetilap 20080713 |
| Air in the Wirsung duct. An unusual finding. | JOP : Journal of the pancreas 20080710 |
| Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. | Liver international : official journal of the International Association for the Study of the Liver 20080701 |
| Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. | Alimentary pharmacology & therapeutics 20080701 |
| Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | Alimentary pharmacology & therapeutics 20080701 |
| Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. | Alimentary pharmacology & therapeutics 20080701 |
| Ursodeoxycholic acid treatment for patients with postcholecystectomy pain and bile microlithiasis. | Gastrointestinal endoscopy 20080701 |
| Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo. | Drug development and industrial pharmacy 20080701 |
| Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. | Journal of pediatric surgery 20080701 |
| Clinical features and management of primary biliary cirrhosis. | World journal of gastroenterology 20080607 |
| Clinical features and management of primary sclerosing cholangitis. | World journal of gastroenterology 20080607 |
| Overlap syndromes among autoimmune liver diseases. | World journal of gastroenterology 20080607 |
| Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers. | Naunyn-Schmiedeberg's archives of pharmacology 20080601 |
| Combination of endoprostheses and oral ursodeoxycholic acid or placebo in the treatment of difficult to extract common bile duct stones. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20080601 |
| Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis. | Biochemical pharmacology 20080601 |
| Current diagnosis and management of primary sclerosing cholangitis. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080601 |
| A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20080501 |
| High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. | Journal of hepatology 20080501 |
| High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. | Journal of hepatology 20080501 |
| Natural history of primary biliary cirrhosis. | Clinics in liver disease 20080501 |
| Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. | Clinics in liver disease 20080501 |
| Hepatic sinusoidal obstruction syndrome in patients undergoing hematopoietic stem cell transplant. | Oncology nursing forum 20080501 |
| [Parenteral nutrition-associated liver disease]. | Nutricion hospitalaria 20080501 |
| Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpura. | World journal of gastroenterology 20080421 |
| Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. | Cancer research 20080415 |
| [Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis]. | MMW Fortschritte der Medizin 20080410 |
| Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. | Digestive diseases and sciences 20080401 |
| [Intrahepatic cholestasis of pregnancy]. | Journal de gynecologie, obstetrique et biologie de la reproduction 20080401 |
| Therapy for nonalcoholic fatty liver disease. | Journal of clinical gastroenterology 20080401 |
| Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes. | Hepatology (Baltimore, Md.) 20080401 |
| Management of cholelithiasis in Italian children: a national multicenter study. | World journal of gastroenterology 20080307 |
| Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. | Alimentary pharmacology & therapeutics 20080301 |
| Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. | Neurotoxicology 20080301 |
| Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent. | European journal of gastroenterology & hepatology 20080301 |
| Severe hemolytic disease of the newborn from anti-e. | Journal of perinatology : official journal of the California Perinatal Association 20080301 |
| [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)]. | Annales de dermatologie et de venereologie 20080301 |
| Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex. | AAPS PharmSciTech 20080301 |
| Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. | World journal of gastroenterology 20080221 |
| Anabolic-androgenic steroids and liver injury. | Liver international : official journal of the International Association for the Study of the Liver 20080201 |
| Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. | Hepatology (Baltimore, Md.) 20080201 |
| Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. | The Journal of clinical investigation 20080201 |
| Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. | Trends in molecular medicine 20080201 |
| Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. | Hepatology (Baltimore, Md.) 20080201 |
| Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. | Journal of pediatric gastroenterology and nutrition 20080201 |
| Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20080201 |
| Granulomatous hepatitis associated with etanercept therapy. | The Journal of rheumatology 20080201 |
| Endoplasmic reticulum stress and diabetic retinopathy. | Vascular health and risk management 20080201 |
| [General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20080110 |
| Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production. | European journal of pharmacology 20080106 |
| Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. | Hepatology (Baltimore, Md.) 20080101 |
| A patient with numerous tablets remaining in the stomach even 5 hours after ingestion. | The American journal of emergency medicine 20080101 |
| Primary biliary cirrhosis. | Orphanet journal of rare diseases 20080101 |
| Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma. | Internal medicine (Tokyo, Japan) 20080101 |
| [Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment]. | Terapevticheskii arkhiv 20080101 |
| [Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20080101 |
| Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax. | Nutrition and cancer 20080101 |
| Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. | Nutrition and cancer 20080101 |
| The medical management of primary sclerosing cholangitis. | Medscape journal of medicine 20080101 |
| The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20080101 |
| Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes. | American journal of nephrology 20080101 |
| Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. | Wiener medizinische Wochenschrift (1946) 20080101 |
| [Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| [Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case]. | Dakar medical 20080101 |
| Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy. | World journal of gastroenterology 20071214 |
| A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. | Gut 20071201 |
| Ursodeoxycholic acid in chronic hepatitis C. | Gut 20071201 |
| The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. | Liver international : official journal of the International Association for the Study of the Liver 20071201 |
| Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20071201 |
| p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. | The Journal of biological chemistry 20071123 |
| Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis. | Gynecologic oncology 20071101 |
| Transplantation trends in primary biliary cirrhosis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071101 |
| Ursodiol in patients with parenteral nutrition-associated cholestasis. | The Annals of pharmacotherapy 20071101 |
| Managing liver dysfunction in parenteral nutrition. | The Proceedings of the Nutrition Society 20071101 |
| Pruritus in pregnancy. | The Journal of family practice 20071101 |
| [Cholestasis of pregnancy]. | Gastroenterologia y hepatologia 20071101 |
| Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. | Gastroenterology 20071101 |
| Thinking outside the cell: the role of extracellular adenosine triphosphate in bile formation. | Gastroenterology 20071101 |
| Gradual improvement of liver function after administration of ursodeoxycholic acid in an infant with a novel ABCB11 gene mutation with phenotypic continuum between BRIC2 and PFIC2. | European journal of gastroenterology & hepatology 20071101 |
| [Pathologic diagnosis of autoimmune liver disease]. | Zhonghua bing li xue za zhi = Chinese journal of pathology 20071101 |
| Bile acids for viral hepatitis. | The Cochrane database of systematic reviews 20071017 |
| Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. | Alimentary pharmacology & therapeutics 20071015 |
| [Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain]. | Medizinische Klinik (Munich, Germany : 1983) 20071015 |
| Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. | The New England journal of medicine 20071011 |
| Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters. | World journal of gastroenterology 20071007 |
| Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts. | Inflammatory bowel diseases 20071001 |
| Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. | Hepatology (Baltimore, Md.) 20071001 |
| Development of autoimmune hepatitis in primary biliary cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20071001 |
| Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. | European journal of gastroenterology & hepatology 20071001 |
| Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom. | Hepatology (Baltimore, Md.) 20071001 |
| Case report: mixed cholestatic/hepatocellular liver injury induced by the herbicide quizalofop-p-ethyl. | Environmental health perspectives 20071001 |
| Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. | Journal of pediatric gastroenterology and nutrition 20071001 |
| [Jeune'disease (asphyxiating thoracic dystrophy) and respiratory failure: importance of early respiratory management with periodic hyperinsufflation]. | Bulletin de l'Academie nationale de medecine 20071001 |
| Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. | Journal of medicinal chemistry 20070906 |
| Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. | Hepatology (Baltimore, Md.) 20070901 |
| Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. | Carcinogenesis 20070901 |
| Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study. | Translational research : the journal of laboratory and clinical medicine 20070901 |
| Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070901 |
| How, why, and when does primary biliary cirrhosis recur after liver transplantation? | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070901 |
| Glycoursodeoxycholic acid and interleukin-10 modulate the reactivity of rat cortical astrocytes to unconjugated bilirubin. | Journal of neuropathology and experimental neurology 20070901 |
| A patient with primary biliary cirrhosis accompanied by Graves disease and Hurthle cell adenoma. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20070901 |
| [Effect of ursodeoxycholic acid in an experimental colon cancer model]. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20070901 |
| Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones. | World journal of gastroenterology 20070828 |
| Gallstones: Article was disappointing. | BMJ (Clinical research ed.) 20070825 |
| Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. | The Journal of biological chemistry 20070803 |
| Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. | The American journal of gastroenterology 20070801 |
| Obstetric cholestasis characterized by extremely elevated serum transaminases. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20070801 |
| Parenteral nutrition related hepato-biliary disease in adults. | Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 20070801 |
| Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. | Journal of pediatric surgery 20070801 |
| Psoriasis treated with ursodeoxycholic acid: three case reports. | Clinical and experimental dermatology 20070701 |
| Human cecal bile acids: concentration and spectrum. | American journal of physiology. Gastrointestinal and liver physiology 20070701 |
| Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. | American journal of physiology. Gastrointestinal and liver physiology 20070701 |
| Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. | Current issues in molecular biology 20070701 |
| Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. | American journal of physiology. Gastrointestinal and liver physiology 20070701 |
| Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. | Transplantation 20070627 |
| Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress. | Life sciences 20070606 |
| Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. | Gut 20070601 |
| Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. | The American journal of gastroenterology 20070601 |
| The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. | European journal of gastroenterology & hepatology 20070601 |
| Crystal structure of chenodeoxycholic acid, ursodeoxycholic acid and their two 3beta,7alpha- and 3beta,7beta-dihydroxy epimers. | Steroids 20070601 |
| Treatment of cholestatic pruritus in children. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070601 |
| The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. | Archives of dermatology 20070601 |
| Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? | Obesity surgery 20070601 |
| [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard]. | MMW Fortschritte der Medizin 20070524 |
| Cholestasis and cholestatic syndromes. | Current opinion in gastroenterology 20070501 |
| Guidelines for therapy of autoimmune liver disease. | Seminars in liver disease 20070501 |
| Gallstones: advances in treatments. More and better choices in the arsenal against the intense pain of a gallbladder attack. | DukeMedicine healthnews 20070501 |
| Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. | Current clinical pharmacology 20070501 |
| Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070415 |
| Hepatology may have problems with putative surrogate outcome measures. | Journal of hepatology 20070401 |
| Caroli's disease: identification and treatment strategy. | Current gastroenterology reports 20070401 |
| [Gallbladder complications after bariatric surgery]. | Gastroenterologie clinique et biologique 20070401 |
| [Intrahepatic cholestasis of pregnancy: a disorder of increased fetal risks. Part I. Maternal condition]. | Ginekologia polska 20070401 |
| A weighted logistic regression model for estimation of recurrence of adenomas. | Statistics in medicine 20070330 |
| Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. | World journal of gastroenterology 20070321 |
| A lean man with nonalcoholic fatty liver disease. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070301 |
| High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. | Current gastroenterology reports 20070301 |
| DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery. | Nanomedicine : nanotechnology, biology, and medicine 20070301 |
| Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. | Journal of gastrointestinal and liver diseases : JGLD 20070301 |
| Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070201 |
| A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients. | Gut 20070201 |
| [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. | Zeitschrift fur Gastroenterologie 20070201 |
| The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable. | The American journal of gastroenterology 20070201 |
| Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity. | Canadian journal of physiology and pharmacology 20070201 |
| Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. | The Cochrane database of systematic reviews 20070124 |
| Biliary symptoms, gallbladder motility, and cholecystectomy. | Hepatology (Baltimore, Md.) 20070101 |
| Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070101 |
| Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. | Gastroenterologie clinique et biologique 20070101 |
| Ciprofloxacin-induced cholestatic jaundice. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| The effects of somatostatin and ursodeoxycholic acid in preventing the ischemic injury of the liver following Pringle maneuver in obstructive jaundice-rat model. | Hepato-gastroenterology 20070101 |
| Primary sclerosing cholangitis. | Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20070101 |
| Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. | Journal of clinical gastroenterology 20070101 |
| Intrahepatic cholestasis of pregnancy. | Orphanet journal of rare diseases 20070101 |
| [Atherogenic dyslipidemia, non-alcohol steatohepatitis, methods of treatment]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| Congenital intrahepatic porto-systemic venous shunt with galactosemia. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. | Journal of women's health (2002) 20070101 |
| [Liver cirrhosis and therapy issues]. | Likars'ka sprava 20070101 |
| Current treatments of primary sclerosing cholangitis. | Current medicinal chemistry 20070101 |
| Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. | Current pharmaceutical design 20070101 |
| Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20070101 |
| [Clinical manifestation of hepatotoxic effect of cytostatic chemicals]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| Chemoprevention of colorectal cancer. | Digestion 20070101 |
| Intrahepatic cholestasis and eclampsia: a case report. | Hypertension in pregnancy 20070101 |
| Left ventricular aneurysms developed in a patient with systemic sclerosis. | Modern rheumatology 20070101 |
| Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation. | International journal of immunopathology and pharmacology 20070101 |
| Cholecystitis during pregnancy. A case report and brief review of the literature. | Clinical and experimental obstetrics & gynecology 20070101 |
| [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| [Correction of functional and structural changes of the intestine by ursosan in patients with absence of the gall-bladder]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| [Extrasecretory liver function disorder in patients with chronic pancreatitis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101 |
| Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence. | International journal of cancer 20061215 |
| [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?]. | Der Internist 20061201 |
| [Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?]. | Der Internist 20061201 |
| Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. | Liver international : official journal of the International Association for the Study of the Liver 20061201 |
| Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061201 |
| Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap. | Fukushima journal of medical science 20061201 |
| New therapies in hepatitis C virus and chronic liver disease: antifibrotics. | Clinics in liver disease 20061101 |
| Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. | Alimentary pharmacology & therapeutics 20061015 |
| Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. | The American journal of gastroenterology 20061001 |
| Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. | Nature clinical practice. Gastroenterology & hepatology 20061001 |
| A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine. | Journal of pediatric gastroenterology and nutrition 20061001 |
| Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. | International journal of cancer 20060915 |
| Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps. | Biochemical pharmacology 20060914 |
| Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. | World journal of gastroenterology 20060907 |
| Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. | The American journal of gastroenterology 20060901 |
| Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. | Journal of gastroenterology and hepatology 20060901 |
| Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. | Alimentary pharmacology & therapeutics 20060901 |
| A prolonged gestational intrahepatic cholestasis: a case report. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060901 |
| Primary sclerosing cholangitis: summary of a workshop. | Hepatology (Baltimore, Md.) 20060901 |
| [Granulomatous hepatitis successfully treated with ursodeoxycholic acid]. | Orvosi hetilap 20060806 |
| Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. | Life sciences 20060801 |
| Deflazacort for type-1 autoimmune hepatitis in a Korean girl. | Journal of Korean medical science 20060801 |
| Overdose of ursodiol in preterm infant is well tolerated. | Pediatric emergency care 20060801 |
| Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. | World journal of gastroenterology 20060728 |
| 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats. | Toxicology and applied pharmacology 20060715 |
| Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. | Alimentary pharmacology & therapeutics 20060715 |
| Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. | Pharmaceutical research 20060701 |
| Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. | The American journal of gastroenterology 20060701 |
| Molecular mechanisms of cholestasis. | Wiener medizinische Wochenschrift (1946) 20060701 |
| [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk]. | MMW Fortschritte der Medizin 20060615 |
| Ursodeoxycholic acid treatment of vanishing bile duct syndromes. | World journal of gastroenterology 20060614 |
| Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid. | International journal of cancer 20060601 |
| Plasma levels of ursodeoxycholic acid in black bears, Ursus americanus: seasonal changes. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20060601 |
| Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. | Hepatology (Baltimore, Md.) 20060601 |
| Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. | Nature clinical practice. Gastroenterology & hepatology 20060601 |
| Effects of choleretics on bile compositions drained from patients with pigment gallstone. | Chinese journal of integrative medicine 20060601 |
| Binding studies of bile acids using the native fluorescence of the tryptophan residue Of Bax protein. | Bioscience reports 20060601 |
| [Targeting of nitric oxide-donor and related drugs]. | Yao xue xue bao = Acta pharmaceutica Sinica 20060601 |
| Deoxycholic acid induces intracellular signaling through membrane perturbations. | The Journal of biological chemistry 20060526 |
| Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. | American journal of physiology. Gastrointestinal and liver physiology 20060501 |
| Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. | European journal of pediatrics 20060501 |
| Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. | Clinical pharmacology and therapeutics 20060501 |
| Treatment of nonalcoholic fatty liver disease. | World journal of gastroenterology 20060414 |
| Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. | Cancer letters 20060408 |
| Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. | Gut 20060401 |
| Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. | Clinical science (London, England : 1979) 20060401 |
| Primary biliary cirrhosis: when and why does the disease develop? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060401 |
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid. | Journal of gastroenterology and hepatology 20060401 |
| Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia. | European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie 20060401 |
| [Primary biliary cirrhosis: a thirteen years experience]. | Revista medica de Chile 20060401 |
| Xanthomonas maltophilia CBS 897.97 as a source of new 7beta- and 7alpha-hydroxysteroid dehydrogenases and cholylglycine hydrolase: improved biotransformations of bile acids. | Steroids 20060301 |
| Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery. | Liver international : official journal of the International Association for the Study of the Liver 20060301 |
| c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model. | International journal of molecular medicine 20060301 |
| Autoimmune hemolytic anemia in an infant with giant cell hepatitis. | American journal of hematology 20060301 |
| Methotrexate for treatment of primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20060301 |
| Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view. | Hepatology (Baltimore, Md.) 20060301 |
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. | Gastroenterology 20060301 |
| Therapy of NAFLD: antioxidants and cytoprotective agents. | Journal of clinical gastroenterology 20060301 |
| Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. | Digestive diseases and sciences 20060301 |
| [Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP)]. | Ceska gynekologie 20060301 |
| Role of ursodeoxycholic acid in lowering ALT in chronic liver disease. | JPMA. The Journal of the Pakistan Medical Association 20060301 |
| Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells. | International journal of cancer 20060201 |
| Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. | Journal of hepatology 20060201 |
| Probing beta relaxation in pharmaceutically relevant glasses by using DSC. | Pharmaceutical research 20060201 |
| Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. | Singapore medical journal 20060201 |
| Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. | The American journal of pathology 20060201 |
| Fetal death in a patient with intrahepatic cholestasis of pregnancy. | Obstetrics and gynecology 20060201 |
| 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. | Gastroenterology 20060201 |
| Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans. | Gastroenterology 20060201 |
| Dexamethasone in the treatment of obstetric cholestasis: a case series. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20060201 |
| The medical management of primary sclerosing cholangitis. | Seminars in liver disease 20060201 |
| Primary sclerosing cholangitis: diagnosis and management. | Current gastroenterology reports 20060201 |
| [Predisposing factors and results of pharmalogical treatment using ursodeoxycholic acid of gallbladder stones in children]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060201 |
| Review article: Drug therapy for non-alcoholic fatty liver disease. | Alimentary pharmacology & therapeutics 20060115 |
| Gallbladder bile composition in patients with Crohn 's disease. | World journal of gastroenterology 20060107 |
| Micellization of conjugated chenodeoxy- and ursodeoxycholates and solubilization of cholesterol into their micelles: comparison with other four conjugated bile salts species. | Chemistry and physics of lipids 20060101 |
| Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. | Medical hypotheses 20060101 |
| Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid. | Placenta 20060101 |
| [Primary biliary cirrhosis and eosinophilia: regression after treatment with ursodeoxycholic acid]. | Gastroenterologia y hepatologia 20060101 |
| Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acid. | Molecular cancer therapeutics 20060101 |
| [Advances in the research of anti-hepatic fibrosis drugs]. | Yao xue xue bao = Acta pharmaceutica Sinica 20060101 |
| Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8). | Molecular pharmaceutics 20060101 |
| Autoimmune pancreatocholangitis: a series of ten patients. | Scandinavian journal of gastroenterology. Supplement 20060101 |
| Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation. | Redox report : communications in free radical research 20060101 |
| Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis. | Anticancer research 20060101 |
| Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20060101 |
| Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20060101 |
| Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20060101 |
| Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management. | MedGenMed : Medscape general medicine 20060101 |
| Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity. | BMC cancer 20060101 |
| Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101 |
| Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. | Journal of perinatal medicine 20060101 |
| Autoimmune cholangitis presented as fever of unknown origin. | Chemotherapy 20060101 |
| Primary biliary cirrhosis. | Annals of hepatology 20060101 |
| Intrahepatic cholestasis of pregnancy: a past and present riddle. | Annals of hepatology 20060101 |
| Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. | Current medicinal chemistry 20060101 |
| Gallstone disease: Microlithiasis and sludge. | Best practice & research. Clinical gastroenterology 20060101 |
| Gallstone disease: Primary and secondary prevention. | Best practice & research. Clinical gastroenterology 20060101 |
| Gallstone disease. Management of common bile-duct stones and associated gallbladder stones: Surgical aspects. | Best practice & research. Clinical gastroenterology 20060101 |
| Cholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with cyclosporin. | Clinical drug investigation 20060101 |
| Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model. | Physiological research 20060101 |
| Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis. | Advances in medical sciences 20060101 |
| Micellar solubilization of selected non-steroidal therapeutic agents by new surface-active agents of the class of the products of oxyethylation of ursodeoxycholic acid. | Polimery w medycynie 20060101 |
| [Non-hepatic manifestations of the overlap syndrome (a case report)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20060101 |
| Fenofibrate-induced liver injury. | World journal of gastroenterology 20051228 |
| Primary biliary cirrhosis. | The New England journal of medicine 20051222 |
| A phase I/II trial of irinotecan-cisplatin combined with an anti-late-diarrhoeal programme to evaluate the safety and antitumour response of this combination therapy in patients with advanced non-small-cell lung cancer. | British journal of cancer 20051212 |
| [Possible treatment modalities of primary sclerosing cholangitis]. | Orvosi hetilap 20051204 |
| Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation. | Bone marrow transplantation 20051201 |
| Medications associated with weight gain. | The Annals of pharmacotherapy 20051201 |
| Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver. | Clinical transplantation 20051201 |
| Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. | Hepatology (Baltimore, Md.) 20051201 |
| Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. | Hepatology (Baltimore, Md.) 20051201 |
| Patients and patience: the pitfalls of primary biliary cirrhosis trials. | Nature clinical practice. Gastroenterology & hepatology 20051201 |
| Development of primary biliary cirrhosis in a patient with Crohn's disease: a case report and review of the literature. | Digestive diseases and sciences 20051201 |
| Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells. | Cancer letters 20051108 |
| Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway. | Journal of molecular and cellular cardiology 20051101 |
| The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20051101 |
| Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20051101 |
| Reflections on therapeutic trials in primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20051101 |
| High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. | Gastroenterology 20051101 |
| Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids. | Gastroenterologie clinique et biologique 20051101 |
| The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. | Toxicology 20051015 |
| Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism. | The Journal of pharmacology and experimental therapeutics 20051001 |
| Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells. | International journal of molecular medicine 20051001 |
| Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. | Journal of clinical gastroenterology 20051001 |
| Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes. | Hepatology (Baltimore, Md.) 20051001 |
| Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20051001 |
| Post-liver transplantation de novo hepatitis with overlap features. | Pathology international 20051001 |
| Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20051001 |
| [The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis (PFIC)]. | Annales de chirurgie 20051001 |
| Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. | Journal of pediatric gastroenterology and nutrition 20051001 |
| Steroids in the management of PBC: why do we need them? | Gastroenterology 20051001 |
| Primary biliary cirrhosis. | The New England journal of medicine 20050922 |
| Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines. | European journal of cancer (Oxford, England : 1990) 20050901 |
| Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050901 |
| Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis. | Zeitschrift fur Gastroenterologie 20050901 |
| Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. | Gastroenterology 20050901 |
| New therapeutical indications of ursodeoxycholic acid. | Romanian journal of gastroenterology 20050901 |
| Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050901 |
| Ursodeoxycholic acid and superoxide anion. | World journal of gastroenterology 20050821 |
| Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. | Journal of hepatology 20050801 |
| Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. | Liver international : official journal of the International Association for the Study of the Liver 20050801 |
| Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. | Gastroenterology 20050801 |
| Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid. | Journal of biochemistry 20050801 |
| Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein. | Die Pharmazie 20050801 |
| Overlap syndromes. | Seminars in liver disease 20050801 |
| The natural history of PBC: has it changed? | Seminars in liver disease 20050801 |
| Future Treatment Options in PBC. | Seminars in liver disease 20050801 |
| Bile acids for liver-transplanted patients. | The Cochrane database of systematic reviews 20050720 |
| Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. | Drug metabolism and disposition: the biological fate of chemicals 20050701 |
| Gamma-glutamyltransferase decreases in patients with the chronic form of schistosomiasis mansoni treated with ursodeoxycholic acid. | Journal of clinical pathology 20050701 |
| Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. | The American journal of gastroenterology 20050701 |
| Pretreatment with ursodeoxycholic acid (UDCA) as a novel pharmacological intervention in hepatobiliary scintigraphy. | Yonsei medical journal 20050630 |
| Prolonged acute hepatitis A mimicking autoimmune hepatitis. | World journal of gastroenterology 20050628 |
| Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor. | Biochemical pharmacology 20050615 |
| [Possibilities in the treatment of primary biliary cirrhosis]. | Orvosi hetilap 20050605 |
| A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. | Journal of hepatology 20050601 |
| Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. | Liver international : official journal of the International Association for the Study of the Liver 20050601 |
| Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. | Journal of the National Cancer Institute 20050601 |
| Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis. | Zeitschrift fur Gastroenterologie 20050601 |
| Karyometry in rectal mucosa of patients with previous colorectal adenomas. | Analytical and quantitative cytology and histology 20050601 |
| Soluble CD40L in plasma of patients with primary biliary cirrhosis. | Annals of the New York Academy of Sciences 20050601 |
| Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats. | Transplant international : official journal of the European Society for Organ Transplantation 20050501 |
| Neonatal Gaucher disease presenting as persistent thrombocytopenia. | Journal of perinatology : official journal of the California Perinatal Association 20050501 |
| [Primary biliary cirrhosis (PBC)]. | Nihon rinsho. Japanese journal of clinical medicine 20050501 |
| [Primary sclerosing cholangitis]. | Nihon rinsho. Japanese journal of clinical medicine 20050501 |
| Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. | World journal of gastroenterology 20050421 |
| Bile acids induce MUC2 overexpression in human colon carcinoma cells. | Cancer 20050415 |
| Review article: current management of primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20050415 |
| Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. | Hepatology (Baltimore, Md.) 20050401 |
| Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. | Journal of clinical gastroenterology 20050401 |
| Chemical synthesis of 24-beta-D-galactopyranosides of bile acids: a new type of bile acid conjugates in human urine. | Chemistry and physics of lipids 20050401 |
| Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells. | Hepatology (Baltimore, Md.) 20050401 |
| Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid. | Biological & pharmaceutical bulletin 20050401 |
| Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis. | Clinical reviews in allergy & immunology 20050401 |
| Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. | Clinical reviews in allergy & immunology 20050401 |
| The potential anti-hBV effect of amantadine in combination with ursodeoxycholic acid and biphenyl dimethyl dicarboxylate in hepG2 2.2.15 cells. | Archives of pharmacal research 20050401 |
| Increasing ursodeoxycholic acid in the enterohepatic circulation of pigs through the administration of living bacteria. | The British journal of nutrition 20050401 |
| [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?]. | MMW Fortschritte der Medizin 20050331 |
| Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment. | Alimentary pharmacology & therapeutics 20050315 |
| Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. | Journal of hepatology 20050301 |
| Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. | Journal of hepatology 20050301 |
| No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20050301 |
| Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. | Fertility and sterility 20050301 |
| Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. | The Journal of pharmacology and experimental therapeutics 20050201 |
| Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go? | European journal of gastroenterology & hepatology 20050201 |
| Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes. | European journal of gastroenterology & hepatology 20050201 |
| Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. | Journal of clinical gastroenterology 20050201 |
| The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. | Gastroenterology 20050201 |
| Examining the increased IgM production and ursodeoxycholic acid treatment in PBC. | Gastroenterology 20050201 |
| Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. | Alimentary pharmacology & therapeutics 20050201 |
| Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis. | Alimentary pharmacology & therapeutics 20050201 |
| Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? | Seminars in oncology 20050201 |
| Primary sclerosing cholangitis: updates in diagnosis and therapy. | World journal of gastroenterology 20050107 |
| Treatment for NASH: the value of histology. | The American journal of gastroenterology 20050101 |
| Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20050101 |
| [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20050101 |
| Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. | Digestive diseases and sciences 20050101 |
| Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. | Digestive diseases and sciences 20050101 |
| Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. | Digestive diseases and sciences 20050101 |
| Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. | Digestive diseases and sciences 20050101 |
| [Case of primary biliary cirrhosis patient with anti-p97/VCP antibodies presenting a mild clinical course]. | Rinsho byori. The Japanese journal of clinical pathology 20050101 |
| Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling. | Nutrition and cancer 20050101 |
| Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model. | Hepato-gastroenterology 20050101 |
| Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. | Journal of pediatric surgery 20050101 |
| Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid. | Hepato-gastroenterology 20050101 |
| Fetal gallstones. | Fetal diagnosis and therapy 20050101 |
| Primary sclerosing cholangitis associated with limy bile and acute pancreatitis. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20050101 |
| Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection. | Hepato-gastroenterology 20050101 |
| Nephrolithiasis as primary symptom in sarcoidosis. | Scandinavian journal of urology and nephrology 20050101 |
| [Assessment of efficacy of the drug litovit as a novel pathogenetic modality in acute virus hepatitis]. | Terapevticheskii arkhiv 20050101 |
| Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20050101 |
| Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. | Nutrition and cancer 20050101 |
| Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20050101 |
| Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20050101 |
| Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. | Best practice & research. Clinical gastroenterology 20041201 |
| Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. | Hepatology (Baltimore, Md.) 20041201 |
| Validation of LC/MS electrospray ionisation method for the estimation of ursodiol in human plasma and its application in bioequivalence study. | Annali di chimica 20041201 |
| [Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial]. | Revista clinica espanola 20041201 |
| Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. | European journal of pharmacology 20041128 |
| [Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis]. | Deutsche medizinische Wochenschrift (1946) 20041105 |
| A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. | Alimentary pharmacology & therapeutics 20041101 |
| The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. | The American journal of gastroenterology 20041101 |
| [Treatment of nonalcoholic steatohepatitis (NASH)]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101 |
| [A case of autoimmune hepatitis followed-up with an oral administration of ursodeoxycholic acid]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101 |
| Mitochondrially-mediated toxicity of bile acids. | Toxicology 20041015 |
| [Intrahepatic cholestasis of pregnancy]. | Orvosi hetilap 20041010 |
| Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy. | Journal of gastroenterology and hepatology 20041001 |
| [Role of ursodeoxycholic acid in pediatric cholestatic disease]. | Gastroenterologie clinique et biologique 20041001 |
| [Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20041001 |
| Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress. | Digestive diseases and sciences 20041001 |
| Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives. | European journal of clinical pharmacology 20040901 |
| Effects of motilin and ursodeoxycholic acid on gastrointestinal myoelectric activity of different origins in fasted rats. | World journal of gastroenterology 20040901 |
| NASH remains without a treatment ... URSO they say. | Journal of pediatric gastroenterology and nutrition 20040901 |
| Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia. | The American journal of gastroenterology 20040901 |
| Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. | The Journal of pediatrics 20040901 |
| Acetaminophen hepatotoxicity: NO to the rescue. | British journal of pharmacology 20040901 |
| Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. | British journal of pharmacology 20040901 |
| Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20040901 |
| Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. | Hepatology (Baltimore, Md.) 20040901 |
| Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. | Gastroenterology 20040901 |
| [Ulcerative colitis. Cancer prevention]. | Zeitschrift fur Gastroenterologie 20040901 |
| Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). | Archives of pharmacal research 20040901 |
| [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?]. | Ugeskrift for laeger 20040802 |
| A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation. | Cell death and differentiation 20040801 |
| Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. | Gastroenterology 20040801 |
| Pharmacologic management of nonalcoholic fatty liver disease. | Clinics in liver disease 20040801 |
| Quality of life in patients with primary biliary cirrhosis. | Hepatology (Baltimore, Md.) 20040801 |
| Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. | Digestive diseases and sciences 20040801 |
| [Hepatitis 2004: an update]. | Therapeutische Umschau. Revue therapeutique 20040801 |
| [Alcoholic and non-alcoholic steatohepatitis]. | Therapeutische Umschau. Revue therapeutique 20040801 |
| [Cholestatic liver diseases]. | Therapeutische Umschau. Revue therapeutique 20040801 |
| Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. | Biochemistry 20040706 |
| Diagnosis and therapy of intrahepatic cholestasis of pregnancy. | Zeitschrift fur Gastroenterologie 20040701 |
| [Therapeutic strategies for hepatitis C]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| [Menthol in the adjuvant treatment of gallbladder stones fragmented by ESWL as an option for reducing doses of urso- and chenodeoxycholic acid]. | Medizinische Klinik (Munich, Germany : 1983) 20040615 |
| Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats. | Virchows Archiv : an international journal of pathology 20040601 |
| Ursodeoxycholic acid for terbinafine-induced toxic hepatitis. | The Annals of pharmacotherapy 20040601 |
| Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces. | FEMS microbiology letters 20040601 |
| Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. | Hepatology (Baltimore, Md.) 20040601 |
| Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. | Liver international : official journal of the International Association for the Study of the Liver 20040601 |
| A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. | Journal of gastroenterology 20040601 |
| Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601 |
| [Gallstones following considerable weight loss and recommendations for their prevention]. | Nederlands tijdschrift voor geneeskunde 20040508 |
| Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. | Toxicological sciences : an official journal of the Society of Toxicology 20040501 |
| Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid. | The American journal of gastroenterology 20040501 |
| Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. | Metabolism: clinical and experimental 20040501 |
| Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20040501 |
| Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins. | Free radical biology & medicine 20040415 |
| Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase. | European journal of gastroenterology & hepatology 20040401 |
| A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. | Hepatology (Baltimore, Md.) 20040401 |
| Fenofibrate for patients with asymptomatic primary biliary cirrhosis. | World journal of gastroenterology 20040315 |
| The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. | The Journal of biological chemistry 20040305 |
| Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. | Journal of autoimmunity 20040301 |
| Negative trials in nonalcoholic steatohepatitis: why they happen and what they teach us. | Hepatology (Baltimore, Md.) 20040301 |
| Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. | Hepatology (Baltimore, Md.) 20040301 |
| Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. | Hepatology (Baltimore, Md.) 20040301 |
| Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs. | Australian veterinary journal 20040301 |
| Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. | European journal of gastroenterology & hepatology 20040301 |
| [Source of pain or scapegoat in the epigastrium: how silent are gallstones?]. | MMW Fortschritte der Medizin 20040219 |
| Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid. | Biochimica et biophysica acta 20040202 |
| Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. | The Journal of nutrition 20040201 |
| Protective effects of ursodeoxycholic acid against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced testicular damage in mice. | Toxicology and applied pharmacology 20040201 |
| Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. | The American journal of gastroenterology 20040201 |
| Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis. | The American journal of gastroenterology 20040201 |
| Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. | Clinics in liver disease 20040201 |
| [Gallstones following considerable weight loss and recommendations for their prevention]. | Nederlands tijdschrift voor geneeskunde 20040124 |
| [Therapy for chronic pancreatitis and the prognosis]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040110 |
| A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. | BJOG : an international journal of obstetrics and gynaecology 20040101 |
| Review article: chemoprevention of colorectal cancer. | Alimentary pharmacology & therapeutics 20040101 |
| [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy]. | Der Internist 20040101 |
| [Primary sclerosing cholangitis]. | Der Internist 20040101 |
| [Autoimmune liver disease: diagnosis and therapy]. | Zeitschrift fur Gastroenterologie 20040101 |
| The protective effect of ursodeoxycholic acid in alloxan-induced diabetes. | Cell biochemistry and function 20040101 |
| Colchicine for primary biliary cirrhosis. | The Cochrane database of systematic reviews 20040101 |
| [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis]. | Klinicheskaia meditsina 20040101 |
| Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity. | Digestion 20040101 |
| [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis]. | Klinicheskaia meditsina 20040101 |
| Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. | Cardiovascular drug reviews 20040101 |
| ICP--the mystery itch. | Midwifery today with international midwife 20040101 |
| Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects. | Digestion 20040101 |
| Options for treatment of primary biliary cirrhosis. | Drugs 20040101 |
| Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial. | Annals of hepatology 20040101 |
| Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. | Anticancer research 20040101 |
| [Treatment of autoimmune hepatic diseases]. | Klinicheskaia meditsina 20040101 |
| Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. | Acta gastro-enterologica Belgica 20040101 |
| [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid]. | Chirurgia italiana 20040101 |
| High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225 |
| Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. | The Journal of biological chemistry 20031205 |
| Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. | The Journal of clinical investigation 20031201 |
| NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. | Journal of hepatology 20031201 |
| A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. | Journal of hepatology 20031201 |
| Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. | Journal of hepatology 20031201 |
| Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20031201 |
| Ursodeoxycholic acid therapy attenuated expression of adhesion molecule in primary biliary cirrhosis. | Internal medicine (Tokyo, Japan) 20031201 |
| Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1 beta and nitric oxide in rat microglia. | Archives of pharmacal research 20031201 |
| Systematic review: ursodeoxycholic acid--adverse effects and drug interactions. | Alimentary pharmacology & therapeutics 20031115 |
| Micelle formation of sodium chenodeoxycholate and solubilization into the micelles: comparison with other unconjugated bile salts. | Biochimica et biophysica acta 20031115 |
| Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. | Surgical endoscopy 20031101 |
| Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. | Journal of gastroenterology and hepatology 20031101 |
| Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. | Annals of surgery 20031101 |
| Natural history of primary biliary cirrhosis. | Clinics in liver disease 20031101 |
| Pediatric-onset primary biliary cirrhosis. | Gastroenterology 20031101 |
| Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study. | Journal of pediatric surgery 20031101 |
| Extreme short bowel syndrome in a full-term neonate--a case report. | Journal of pediatric surgery 20031101 |
| Adjuvant medical therapies after portoenterostomy for biliary atresia: time for randomized controlled trial. | Journal of pediatric gastroenterology and nutrition 20031101 |
| [Primary biliary cirrhosis and pregnancy: benefit of ursodeoxycholic acid therapy]. | Gastroenterologia y hepatologia 20031101 |
| Ursodeoxycholic acid treatment of idiopathic thrombocytopenic purpura with liver dysfunction. | European journal of haematology 20031101 |
| Metabolic changes in Clostridium absonum ATCC 27555 accompanying induction of epimerization of a primary bile acid. | Current microbiology 20031101 |
| Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis. | Digestive diseases and sciences 20031101 |
| [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis]. | Zhonghua fu chan ke za zhi 20031101 |
| An unusual combination of relapsing and cholestatic hepatitis A in childhood. | Yonsei medical journal 20031030 |
| Gallstones - approach to medical management. | MedGenMed : Medscape general medicine 20031015 |
| Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. | Journal of hepatology 20031001 |
| Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. | QJM : monthly journal of the Association of Physicians 20031001 |
| Normalization of methotrexate-induced high levels of serum transaminases after ursodeoxycholic acid administration in a rheumatoid arthritis patient. | Rheumatology (Oxford, England) 20031001 |
| Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment. | European journal of clinical investigation 20031001 |
| Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. | Hepatology (Baltimore, Md.) 20031001 |
| Effects of ursodeoxycholic acid on photodynamic therapy in a murine tumor model. | Photochemistry and photobiology 20031001 |
| [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital]. | Ugeskrift for laeger 20030929 |
| Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. | Cancer letters 20030925 |
| [Treatment of primary biliary cirrhosis]. | Orvosi hetilap 20030907 |
| Chemoprevention of colorectal cancer in ulcerative colitis. | International journal of colorectal disease 20030901 |
| Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. | Gut 20030901 |
| Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. | Gut 20030901 |
| Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. | ANZ journal of surgery 20030901 |
| Apoptosis in hepatitis C. | Journal of viral hepatitis 20030901 |
| In the blood. | Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20030901 |
| Disorders of bile formation and biliary transport. | Gastroenterology clinics of North America 20030901 |
| Determination of ursodeoxycholic acid in pharmaceutical preparations by capillary electrophoresis with indirect UV detection. | Journal of pharmaceutical and biomedical analysis 20030808 |
| Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis. | Journal of clinical gastroenterology 20030801 |
| Acute seronegative hepatitis C manifesting itself as adult giant cell hepatitis--a case report and review of literature. | Medical science monitor : international medical journal of experimental and clinical research 20030801 |
| Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. | The Journal of pharmacology and experimental therapeutics 20030701 |
| Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. | Journal of hepatology 20030701 |
| Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. | Journal of hepatology 20030701 |
| Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. | Hepatology (Baltimore, Md.) 20030701 |
| Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. | Hepatology (Baltimore, Md.) 20030701 |
| Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. | Cancer research 20030701 |
| Simultaneous occurrence of PSC and MS in a patient. | Digestive diseases and sciences 20030701 |
| Choleretic actions of insulin-like growth factor-I, prednisolone, and ursodeoxycholic acid in rats. | Digestive diseases and sciences 20030701 |
| Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats. | Chinese medical journal 20030701 |
| [Autoimmune hepatitis during pregnancy]. | Harefuah 20030701 |
| [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases]. | La Tunisie medicale 20030701 |
| Studying pruritus in the 21st century. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030701 |
| Natural history of pruritus in primary biliary cirrhosis. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030701 |
| [Clinical features of primary biliary cirrhosis and treatment of it by integrated traditional Chinese and western medicine]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20030701 |
| Cytotoxic mechanisms of hydrosulfide anion and cyanide anion in primary rat hepatocyte cultures. | Toxicology 20030630 |
| Genetic cholestasis. | Deutsche medizinische Wochenschrift (1946) 20030613 |
| Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis. | Hepatology (Baltimore, Md.) 20030601 |
| A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20030601 |
| [Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030601 |
| The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20030601 |
| [Intrahepatic cholestasis of pregnancy]. | Nederlands tijdschrift voor geneeskunde 20030531 |
| Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. | The Journal of pharmacology and experimental therapeutics 20030501 |
| Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. | Journal of lipid research 20030501 |
| 'Drug reaction to ursodeoxycholic acid: lichenoid drug eruption in an infant using ursodeoxycholic acid for neonatal hepatitis', by Buyukgebiz B, et all. | Journal of pediatric gastroenterology and nutrition 20030501 |
| Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes. | BJOG : an international journal of obstetrics and gynaecology 20030501 |
| [Sclerosing cholangitis as a complication of Langerhans'cell histiocytosis]. | La Revue de medecine interne 20030501 |
| Primary sclerosing cholangitis associated with lupus nephritis: a rare association. | Digestive diseases and sciences 20030501 |
| Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030501 |
| Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030501 |
| Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030501 |
| Bile duct disorders. | Clinics in liver disease 20030501 |
| Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study. | Transplantation 20030415 |
| Factors affecting the apparent solubility of ursodeoxycholic acid in the grinding process. | International journal of pharmaceutics 20030414 |
| Review article: pruritus in cholestatic and other liver diseases. | Alimentary pharmacology & therapeutics 20030401 |
| Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. | Hepatology (Baltimore, Md.) 20030401 |
| A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. | Hepatology (Baltimore, Md.) 20030401 |
| Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. | Gastroenterology 20030401 |
| Ursodiol: good drug makes good. | Gastroenterology 20030401 |
| [Ursodeoxycholic acid therapy in rats with intrahepatic cholestasis]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20030401 |
| Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. | European journal of pharmacology 20030319 |
| Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. | British journal of cancer 20030310 |
| Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors. | Molecular pharmacology 20030301 |
| High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. | Journal of pediatric surgery 20030301 |
| Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid. | Zeitschrift fur Gastroenterologie 20030301 |
| [Diseases of the intrahepatic bile duct: diagnosis and principles of treatment]. | Gastroenterologie clinique et biologique 20030301 |
| [Primary biliary cirrhosis]. | Gastroenterologie clinique et biologique 20030301 |
| [Interview: questions to Professor Raoul Poupon]. | Gastroenterologie clinique et biologique 20030301 |
| [Ursodeoxycholic acid/dapsone interaction]. | Annales de dermatologie et de venereologie 20030301 |
| [Primary biliary cirrhosis. Primary sclerosing cholangitis]. | Gastroenterologie clinique et biologique 20030301 |
| The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis. | Cancer letters 20030227 |
| Novel channel structure of bile acid-guest inclusion complex formed between ursodeoxycholic acid and phenanthrene. | Chemical & pharmaceutical bulletin 20030201 |
| Increase of bile acid production by tacrolimus in the rat liver. | Transplantation proceedings 20030201 |
| Diagnosis and management of hepatic copper accumulation in a Skye terrier. | The Journal of small animal practice 20030201 |
| Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. | Liver international : official journal of the International Association for the Study of the Liver 20030201 |
| [Gallstones--natural history and conservative management]. | Therapeutische Umschau. Revue therapeutique 20030201 |
| [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. | Annales de medecine interne 20030201 |
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030201 |
| Mitochondrially mediated synergistic cell killing by bile acids. | Biochimica et biophysica acta 20030120 |
| [Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis]. | Medicina clinica 20030118 |
| Idiotype-anti-idiotype-based noncompetitive enzyme-linked immunosorbent assay of ursodeoxycholic acid 7-N-acetylglucosaminides in human urine with subfemtomole range sensitivity. | Journal of immunological methods 20030115 |
| Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? | Alimentary pharmacology & therapeutics 20030101 |
| Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. | American journal of hematology 20030101 |
| [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient]. | Gastroenterologia y hepatologia 20030101 |
| Methotrexate therapy for primary biliary cirrhosis. | The American journal of gastroenterology 20030101 |
| Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. | The American journal of gastroenterology 20030101 |
| [Extraintestinal manifestations]. | Zeitschrift fur Gastroenterologie 20030101 |
| [Cholestasis. Recent diagnostic and therapeutic acquisitions]. | Recenti progressi in medicina 20030101 |
| [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101 |
| [Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder]. | Terapevticheskii arkhiv 20030101 |
| [Treatment of cholestatic liver diseases]. | Duodecim; laaketieteellinen aikakauskirja 20030101 |
| Bile acids for viral hepatitis. | The Cochrane database of systematic reviews 20030101 |
| Bile acids for primary sclerosing cholangitis. | The Cochrane database of systematic reviews 20030101 |
| Bezafibrate treatment: a new medical approach for PBC patients? | Journal of gastroenterology 20030101 |
| New weapon for primary biliary cirrhosis from Japan. | Journal of gastroenterology 20030101 |
| [Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis]. | Gastroenterologia y hepatologia 20030101 |
| [Is pre-operative treatment with ursodeoxycholic acid useful in reducing relapses in acute biliary pancreatitis?]. | Anales del sistema sanitario de Navarra 20030101 |
| [The problem of biliary sludge]. | Klinicheskaia meditsina 20030101 |
| The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. | Oncology reports 20030101 |
| Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. | Journal of gastroenterology 20030101 |
| Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid. | Journal of gastroenterology 20030101 |
| Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study. | Digestion 20030101 |
| Caroli's disease: 6 case studies. | Acta gastroenterologica Latinoamericana 20030101 |
| [Treatment of cholestatic liver disease]. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101 |
| [Bile acids in the process of canalicular bile formation]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20030101 |
| The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense. | Acta gastro-enterologica Belgica 20030101 |
| Microlithiasis: an important cause of 'idiopathic' acute pancreatitis? | Annals of hepatology 20030101 |
| Terbinafine hepatotoxicity. A case report and review of literature. | Annals of hepatology 20030101 |
| [Molecular mechanisms of bile formation and cholestatic diseases]. | Bulletin de l'Academie nationale de medecine 20030101 |
| [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report]. | Orvosi hetilap 20021229 |
| [Intrahepatic cholestasis in pregnancy. What to consider in jaundice and pruritus]. | MMW Fortschritte der Medizin 20021212 |
| Antioxidant properties of ursodeoxycholic acid. | Biochemical pharmacology 20021201 |
| Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. | Liver 20021201 |
| [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]. | Zeitschrift fur Gastroenterologie 20021201 |
| The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. | European journal of gastroenterology & hepatology 20021201 |
| Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20021201 |
| Ursodeoxycholic acid as an alternative therapy for autoimmune pancreatitis. | Internal medicine (Tokyo, Japan) 20021201 |
| Autoimmune pancreatitis successfully treated with ursodeoxycholic acid. | Internal medicine (Tokyo, Japan) 20021201 |
| Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. | Journal of experimental & clinical cancer research : CR 20021201 |
| Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). | Biochemistry 20021112 |
| Markov models in primary biliary cirrhosis. | Gastroenterology 20021101 |
| Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20021101 |
| Effect of ursodeoxycholic acid on hepatic steatosis in rats. | Digestive diseases and sciences 20021101 |
| Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders. | Journal of gastroenterology and hepatology 20021101 |
| Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. | Southern medical journal 20021101 |
| Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system. | Antiviral chemistry & chemotherapy 20021101 |
| Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. | Journal of pharmaceutical sciences 20021001 |
| Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis. | Hepatology (Baltimore, Md.) 20021001 |
| Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. | Gastroenterology 20021001 |
| Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. | Gastroenterology 20021001 |
| Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy. | Haematologica 20021001 |
| [The use of surgical endo-prosthesis in the treatment of choledocolithiasis in the elderly. Personal experience]. | Minerva chirurgica 20021001 |
| Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. | The American journal of gastroenterology 20021001 |
| [Clinical analysis of 22 patients with primary biliary cirrhosis]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20021001 |
| Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs. | Digestive diseases and sciences 20021001 |
| Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease. | Internal medicine (Tokyo, Japan) 20021001 |
| [Development of bile acid therapy; from a choleretic to an immunomodulator, and at present time]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20021001 |
| Intrahepatic cholestasis of pregnancy. | The Netherlands journal of medicine 20021001 |
| [Primary sclerosing cholangitis. Early dilatation saves lives]. | MMW Fortschritte der Medizin 20020926 |
| Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. | Blood 20020915 |
| [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis]. | Deutsche medizinische Wochenschrift (1946) 20020906 |
| [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis]. | Deutsche medizinische Wochenschrift (1946) 20020906 |
| Management of nonalcoholic steatohepatitis: an analytic review. | Journal of clinical gastroenterology 20020901 |
| Treatment of itching associated with intrahepatic cholestasis of pregnancy. | The Annals of pharmacotherapy 20020901 |
| Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. | Hepatology (Baltimore, Md.) 20020901 |
| Drug reaction to ursodeoxycholic acid: lichenoid drug eruption in an infant using ursodeoxycholic acid for neonatal hepatitis. | Journal of pediatric gastroenterology and nutrition 20020901 |
| [Autoimmune hepatitis and overlap syndrome: therapy]. | Praxis 20020821 |
| Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities. | Hepatology (Baltimore, Md.) 20020801 |
| Primary sclerosing cholangitis: a premalignant condition. | Gastroenterology 20020801 |
| Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020801 |
| Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis. | Journal of pediatric gastroenterology and nutrition 20020801 |
| Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial. | The American journal of gastroenterology 20020801 |
| Fenofibrate treatment in patients with primary biliary cirrhosis. | The American journal of gastroenterology 20020801 |
| Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate. | European journal of clinical investigation 20020801 |
| Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers. | Scandinavian journal of gastroenterology 20020801 |
| Treatment strategies in autoimmune hepatitis. | Clinics in liver disease 20020801 |
| Relationship between tumor cell load and sensitivity to the cytostatic effect of two novel platinum-bile acid complexes, Bamet-D3 and Bamet-UD2. | Journal of drug targeting 20020801 |
| Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats. | Autonomic neuroscience : basic & clinical 20020731 |
| Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. | The Journal of infectious diseases 20020715 |
| Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. | Hepatology (Baltimore, Md.) 20020701 |
| Serum plant sterols and biliary cholesterol secretion in humans: studies with ursodeoxycholic acid. | Journal of lipid research 20020701 |
| Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease. | American journal of hematology 20020701 |
| [A case-control study of prevention of irinotecan-induced diarrhea: the reducing side effects of irinotecan by oral alkalization combined with control of defecation]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020701 |
| Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism. | European journal of clinical investigation 20020701 |
| Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020701 |
| Effect of ursodeoxycholic acid on hydrogen peroxide induced lipid peroxidation in sheep liver mitochondria. | Indian journal of physiology and pharmacology 20020701 |
| Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. | Digestive diseases and sciences 20020601 |
| Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes. | Prescrire international 20020601 |
| An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis. | Liver 20020601 |
| [A 67 year-old man consults for icterus]. | Journal de chirurgie 20020601 |
| Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: relevance to the cytoprotective function of ursodeoxycholate. | Pharmacology 20020501 |
| Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats. | Gut 20020501 |
| Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. | Hepatology (Baltimore, Md.) 20020501 |
| Does ursodeoxycholic acid cause lichenoid eruption? | Gastroenterology 20020501 |
| Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. | Carcinogenesis 20020501 |
| [Drug-induced liver diseases]. | Zeitschrift fur Gastroenterologie 20020501 |
| Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. | Molecular pharmacology 20020401 |
| Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. | Hepatology (Baltimore, Md.) 20020401 |
| Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. | Hepatology (Baltimore, Md.) 20020401 |
| Gallbladder management in obesity surgery. | Obesity surgery 20020401 |
| [Ursodeoxycholic acid promotes liver regeneration after partial hepatectomy in bile duct obstructive rats]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20020401 |
| Beta-carotene-induced hepatic fibrosis. | Digestive diseases and sciences 20020401 |
| Autoimmune cholangiopathy associated with systemic lupus erythematosus. | Liver 20020401 |
| Choledocholithiasis in an infant of extremely low birthweight. | Journal of paediatrics and child health 20020401 |
| Effect of ursodeoxycholic acid on free radical mediated DNA damage--an in vitro study. | Indian journal of physiology and pharmacology 20020401 |
| [Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope]. | Lakartidningen 20020321 |
| [Treatment of cholestatic liver diseases]. | Medizinische Klinik (Munich, Germany : 1983) 20020315 |
| Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide. | Pediatric research 20020301 |
| Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. | Gastroenterology 20020301 |
| The UDCA dosage deficit: a fate shared with CDCA. | European journal of gastroenterology & hepatology 20020301 |
| Micelle formation of sodium deoxycholate and sodium ursodeoxycholate (part 1). | Biochimica et biophysica acta 20020227 |
| Solubilization of cholesterol and polycyclic aromatic compounds into sodium bile salt micelles (part 2). | Biochimica et biophysica acta 20020227 |
| Stability of oral suspensions of ursodiol made from tablets. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020215 |
| [Fatty liver and raised gamma-GT: it can happen to abstainers, too]. | MMW Fortschritte der Medizin 20020214 |
| Use of ursodeoxycholic acid in patients with liver disease. | Current gastroenterology reports 20020201 |
| Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. | Hepatology (Baltimore, Md.) 20020201 |
| Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. | Journal of hepatology 20020201 |
| Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis. | Clinical science (London, England : 1979) 20020201 |
| Parenteral nutrition-associated liver complications in children. | Pharmacotherapy 20020201 |
| Acute cholestatic hepatitis after exposure to isoflurane. | The Annals of pharmacotherapy 20020201 |
| Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats. | Japanese journal of cancer research : Gann 20020201 |
| [A case of primary sclerosing cholangitis presenting transient hypoperfusion and treated with bezafibrate beneficially]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020201 |
| Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+. | The journal of medical investigation : JMI 20020201 |
| Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. | Journal of gastroenterology and hepatology 20020201 |
| [Influence of ursodeoxycholic acid on the therapeutic effects of low-calorie diet in obesity and hyperlipidemia rats with steatohepatitis]. | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20020201 |
| Benefit of transplantation in primary biliary cirrhosis between 1985-1997. | Transplantation 20020127 |
| Obstetric cholestasis: outcome with active management. | European journal of obstetrics, gynecology, and reproductive biology 20020110 |
| 7alpha-OH epimerisation of bile acids via oxido-reduction with Xanthomonas maltophilia. | Steroids 20020101 |
| Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. | The Journal of surgical research 20020101 |
| Chemoprevention of colorectal cancer. | The American journal of gastroenterology 20020101 |
| Harnois et al.: Study of high-dose ursodeoxycholic acid. | The American journal of gastroenterology 20020101 |
| Bile salts modulate chronic ethanol-induced hepatotoxicity. | Alcohol and alcoholism (Oxford, Oxfordshire) 20020101 |
| [Primary biliary cirrhosis]. | Nihon rinsho. Japanese journal of clinical medicine 20020101 |
| [Cholelithiasis]. | Nihon rinsho. Japanese journal of clinical medicine 20020101 |
| Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. | Journal of the Society for Gynecologic Investigation 20020101 |
| A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation. | Bone marrow transplantation 20020101 |
| Ursodeoxycholic acid for primary biliary cirrhosis. | The Cochrane database of systematic reviews 20020101 |
| [Disturbances in biliary secretion during tissue hypoxia and attempts at their corrections]. | Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20020101 |
| Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study. | International journal of urology : official journal of the Japanese Urological Association 20020101 |
| The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study. | Hepato-gastroenterology 20020101 |
| Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients. | Hepato-gastroenterology 20020101 |
| Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid. | Journal of perinatal medicine 20020101 |
| Liver regeneration enhanced by orally administered ursodesoxycholic acid is mediated by immunosuppression in partially hepatectomized rats. | The American journal of Chinese medicine 20020101 |
| Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. | The Cochrane database of systematic reviews 20020101 |
| Antioxidative effect of ursodeoxycholic acid in the liver of rats with oxidative stress caused by gamma-irradiation. | Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20020101 |
| [Non-alcoholic steatohepatitis]. | Revista de gastroenterologia de Mexico 20020101 |
| [Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report]. | Revista de gastroenterologia de Mexico 20020101 |
| [Biliary stents for reconstruction in bile duct injuries. The role of bile acids]. | Revista de gastroenterologia de Mexico 20020101 |
| Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. | Hepato-gastroenterology 20020101 |
| New strategies for the treatment of gallstone disease. | Scandinavian journal of gastroenterology. Supplement 20020101 |
| Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration. | International journal of clinical pharmacology research 20020101 |
| [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy]. | La Clinica terapeutica 20020101 |
| [Cholestasis from ticlopidine: two clinical cases]. | Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna 20020101 |
| Non-alcoholic steato-hepatitis. | Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20020101 |
| Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. | Annals of hepatology 20020101 |
| Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid. | Annals of hepatology 20020101 |
| [Cholestatic liver disease in children]. | Przeglad epidemiologiczny 20020101 |
| Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid. | The Journal of biological chemistry 20011214 |
| Effect of bile acids on absorption of nitrendipine in healthy subjects. | British journal of clinical pharmacology 20011201 |
| Effect of colestimide on intestinal absorption of ursodeoxycholic acid in men. | International journal of clinical pharmacology and therapeutics 20011201 |
| Ursodiol for all? | The American journal of gastroenterology 20011201 |
| [Therapy of alcoholic and non-alcoholic fatty liver]. | Der Internist 20011201 |
| Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs. | The Journal of pharmacy and pharmacology 20011201 |
| Hepatic hydroxylation of bile acids and chronic liver diseases: do transporters play a mechanistic role? | Journal of gastroenterology and hepatology 20011201 |
| A female with asymptomatic primary biliary cirrhosis associated with pernicious anemia. | Journal of gastroenterology and hepatology 20011201 |
| Management of interferon therapy nonresponders. | Clinics in liver disease 20011101 |
| Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? | The American journal of gastroenterology 20011101 |
| Ursodeoxycholic acid action on the transport function of the small intestine in normal and cystic fibrosis mice. | The Journal of pharmacy and pharmacology 20011101 |
| [Clinical characteristics of primary biliary cirrhosis with Sjögren's syndrome of 20 cases]. | Zhonghua nei ke za zhi 20011101 |
| Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. | The Journal of biological chemistry 20011019 |
| Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. | The Journal of biological chemistry 20011019 |
| Effects of bile acids on the humoral immune response: a mechanistic approach. | Life sciences 20011005 |
| A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. | Gastroenterology 20011001 |
| Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver. | Alcohol (Fayetteville, N.Y.) 20011001 |
| Mucolipidosis II (I-cell disease) presenting as neonatal cholestasis. | Journal of inherited metabolic disease 20011001 |
| [Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C]. | Nihon rinsho. Japanese journal of clinical medicine 20011001 |
| Biliary excretion of tauroursodeoxycholate-3-sulfate in the rat. | Steroids 20010901 |
| Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. | Alimentary pharmacology & therapeutics 20010901 |
| Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. | Japanese journal of cancer research : Gann 20010901 |
| Ursodeoxycholic acid and in vitro vasoactivity of hydrophobic bile acids. | Digestive diseases and sciences 20010901 |
| Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? | Journal of hepatology 20010901 |
| The natural history of primary biliary cirrhosis: of genes and cooperation. | Journal of hepatology 20010901 |
| Thermal behavior of ursodeoxycholic acid in urea: identification of anomalous peak in the thermal analysis. | Drug development and industrial pharmacy 20010901 |
| Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon. | Cancer letters 20010828 |
| Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. | Biochemistry 20010828 |
| Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes. | Mutation research 20010822 |
| Stimulation of ATP secretion in the liver by therapeutic bile acids. | The Biochemical journal 20010815 |
| Ursodeoxycholic acid causing exacerbation of dermatitis herpetiformis. | Journal of the American Academy of Dermatology 20010801 |
| Ursodiol prevents UC-associated CRC. | Gastroenterology 20010801 |
| Lichenoid eruptions due to ursodeoxycholic acid administration. | Gastroenterology 20010801 |
| Prevention of colon cancer with ursodiol in ulcerative colitis. | Inflammatory bowel diseases 20010801 |
| Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. | Gastroenterology 20010701 |
| A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia. | Journal of gastroenterology and hepatology 20010701 |
| Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography. | Endoscopy 20010701 |
| Fetal bile acid metabolism: analysis of urinary 3beta-monohydroxy-delta(5) bile acid in preterm infants. | Biology of the neonate 20010701 |
| Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | Journal of hepatology 20010701 |
| Flipping over flippases. | Journal of pediatric gastroenterology and nutrition 20010701 |
| The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. | Expert opinion on investigational drugs 20010701 |
| Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors. | The Journal of pharmacology and experimental therapeutics 20010601 |
| Effect of bezafibrate in primary biliary cirrhosis: a pilot study. | Liver 20010601 |
| Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. | Endoscopy 20010601 |
| Effect of ursodeoxycholate in University of Wisconsin solution on long term preservation of rat livers. | The European journal of surgery = Acta chirurgica 20010601 |
| Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20010601 |
| Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity. | Journal of drug targeting 20010601 |
| Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. | International journal of oncology 20010501 |
| The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. | Gastroenterology 20010501 |
| MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. | Gastroenterology 20010501 |
| Effects of deoxycholic acid and its epimers on lipid peroxidation in isolated rat hepatocytes. | Journal of biochemistry 20010501 |
| Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis. | Journal of gastroenterology and hepatology 20010501 |
| Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. | Journal of lipid research 20010501 |
| High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. | The American journal of gastroenterology 20010501 |
| Autoimmune liver disease. Current standards, future directions. | Clinics in liver disease 20010501 |
| Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate. | Clinical biochemistry 20010501 |
| Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future? | Journal of hepatology 20010501 |
| Synthetic bile acid derivatives induce nonapoptotic death of human retinal pigment epithelial cells. | Current eye research 20010501 |
| Interferon versus interferon and UDCA combined therapy in chronic hepatitis C. | Medical science monitor : international medical journal of experimental and clinical research 20010501 |
| Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients. | International journal of cancer 20010415 |
| Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. | Biochimica et biophysica acta 20010403 |
| Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. | Journal of clinical gastroenterology 20010401 |
| Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding. | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20010401 |
| Primary sclerosing cholangitis. | Seminars in gastrointestinal disease 20010401 |
| Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. | The Journal of maternal-fetal medicine 20010401 |
| Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. | Hepatology (Baltimore, Md.) 20010301 |
| High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization. | Journal of pharmaceutical and biomedical analysis 20010301 |
| Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. | Journal of lipid research 20010301 |
| Hypocholesterolemic effect of bile acid sulfonate analogs in hamsters. | Biological & pharmaceutical bulletin 20010301 |
| Treatment of cholestasis and cholestatic disorders. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010301 |
| Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. | Journal of hepatology 20010301 |
| Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat. | Journal of pediatric gastroenterology and nutrition 20010301 |
| [3 beta-Hydroxysteroid-delta 5-oxidoreductase/isomerase deficiency]. | Nihon rinsho. Japanese journal of clinical medicine 20010301 |
| An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. | Proceedings of the National Academy of Sciences of the United States of America 20010227 |
| Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. | Cancer letters 20010210 |
| Clinical studies with silymarin: fibrosis progression is the end point. | Hepatology (Baltimore, Md.) 20010201 |
| Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. | Pharmacology 20010201 |
| Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature. | The American journal of gastroenterology 20010201 |
| The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis. | The American journal of gastroenterology 20010201 |
| No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study. | European journal of gastroenterology & hepatology 20010201 |
| Ursodeooxycholic acid for primary biliary cirrhosis. | Journal of hepatology 20010201 |
| Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. | Annals of internal medicine 20010116 |
| Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research. | Annals of internal medicine 20010116 |
| Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group. | Alimentary pharmacology & therapeutics 20010101 |
| Use of ursodeoxycholic acid in liver diseases. | Journal of gastroenterology and hepatology 20010101 |
| Long-term evaluation of extracorporeal shock-wave lithotripsy for cholesterol gallstones. | Journal of gastroenterology and hepatology 20010101 |
| [Experience in treatment of chronic toxic hepatitis by ursodeoxicholic acid]. | Meditsina truda i promyshlennaia ekologiia 20010101 |
| Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype. | Neuroscience 20010101 |
| [Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study]. | Therapie 20010101 |
| [Advances in the diagnosis and treatment of cholelithiasis]. | Terapevticheskii arkhiv 20010101 |
| [Effects of bile acid preparations on DNA biosynthesis, apoptosis, and necrosis in hepatocytes in vitro]. | Voprosy meditsinskoi khimii 20010101 |
| Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. | Lupus 20010101 |
| [Correction of metabolic disturbances in patients with cholestasis]. | Likars'ka sprava 20010101 |
| [Ursodeoxycholic acid as the main treatment of hepatobiliary diseases in children and teenagers]. | Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal 20010101 |
| Treatment of primary biliary cirrhosis. | Journal of physiology, Paris 20010101 |
| [Treatment of intrahepatic lithiasis]. | Gastroenterologie clinique et biologique 20010101 |
| [The experience of the use of Ursosan in the differential diagnosis of gall bladder's polypoid formations]. | Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal 20010101 |
| Interventions for treating cholestasis in pregnancy. | The Cochrane database of systematic reviews 20010101 |
| [Liver and pregnancy. Questions for Doctor Yannick Bacq]. | Gastroenterologie clinique et biologique 20010101 |
| Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid. | Anticancer research 20010101 |
| Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. | Digestion 20010101 |
| Extracorporeal shock wave lithotripsy of gallstones with oral dissolution. Results in course of ten years in Czech Republic in correlation to indication criteria. | Sbornik lekarsky 20010101 |
| [Morphological changes in rat liver in toxic drug-induced hepatitis and stimulation of repair processes]. | Morfologiia (Saint Petersburg, Russia) 20010101 |
| Drug therapy of primary biliary diseases: classical and modern strategies. | Journal of cellular and molecular medicine 20010101 |
| Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. | Journal of neurochemistry 20001201 |
| Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease. | Digestive diseases and sciences 20001001 |
| Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases. | European journal of gastroenterology & hepatology 20000301 |
| Ursodeoxycholic acid treatment in children with Byler disease. | Pediatrics international : official journal of the Japan Pediatric Society 19991201 |
| Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. | European journal of gastroenterology & hepatology 19991001 |
| Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. | Biochemical and biophysical research communications 19990924 |
| Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. | Cell death and differentiation 19990901 |
| Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury. | Journal of hepatology 19990801 |
| The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue. | Cancer letters 19981225 |
| [Cholestasis: drug therapy]. | Praxis 19981111 |
| Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. | Gastroenterology 19980901 |
| [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis]. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 19980701 |
| Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. | Molecular medicine (Cambridge, Mass.) 19980301 |
| Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course. | Journal of clinical ultrasound : JCU 19980101 |
| Intragastric administration of ursodeoxycholic acid suppresses immunoglobulin secretion by lymphocytes from liver, but not from peripheral blood, spleen or Peyer's patches in mice. | International journal of immunopharmacology 19980101 |
| [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid]. | Zeitschrift fur Gastroenterologie 19971201 |
| Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes. | Biochemical and biophysical research communications 19971126 |
| Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats. | Scandinavian journal of gastroenterology 19970901 |
| Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial. | Journal of gastroenterology 19970201 |
| Serial quantitative liver function tests in patients with primary biliary cirrhosis: a prospective long-term study. | Digestion 19970101 |
| Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis. | Digestive diseases and sciences 19961101 |
| Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. | Gastroenterology 19960701 |
| Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. | European journal of pharmacology 19960404 |
| Improvement of peripheral blood lymphocyte subsets in primary biliary cirrhosis after ursodeoxycholic acid therapy. | Journal of gastroenterology and hepatology 19960401 |
| Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy. | Journal of gastroenterology and hepatology 19960401 |
| Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. | Carcinogenesis 19960301 |
| [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-]. | Zeitschrift fur Gastroenterologie 19960301 |
| Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation. | European journal of gastroenterology & hepatology 19960301 |
| Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. | Journal of immunology (Baltimore, Md. : 1950) 19960215 |
| Ultrastructural features of danazol-induced cholestasis: a case study. | Ultrastructural pathology 19960101 |
| The impact of continuous subcutaneous infusion of octreotide on gallstone formation in acromegalic patients. | The Journal of clinical endocrinology and metabolism 19951101 |
| Ursodeoxycholic acid for the treatment of flucloxacillin-associated cholestasis. | Journal of hepatology 19950101 |
| Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. | Gut 19950101 |
| Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis. | Journal of hepatology 19941001 |
| Does ursodeoxycholic acid have a place in the treatment of amiodarone-induced cholestasis? | Journal of clinical gastroenterology 19940301 |
| Cholelithiasis and acromegaly: therapeutic strategies. | Clinical endocrinology 19940301 |
| Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat. | European journal of clinical investigation 19931201 |
| Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. | Journal of lipid research 19931101 |
| Oral and contact dissolution of gallstones. | American journal of surgery 19930401 |
| Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. | Journal of hepatology 19930201 |
| Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function. | European journal of clinical pharmacology 19930101 |
| Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor. | Biochemical and biophysical research communications 19921030 |
| [Effects of therapy with bis-hemisuccinate of ursodeoxycholic acid bisodium salt in patients with chronic hepatitis]. | Minerva medica 19920601 |
| Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat. | Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19920501 |
| Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid. | Zeitschrift fur Gastroenterologie 19920301 |
| Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. | Hepatology (Baltimore, Md.) 19911201 |
| Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. | The American journal of gastroenterology 19910901 |
| Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin. | Journal of Korean medical science 19910601 |
| [Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment]. | Gastroenterologie clinique et biologique 19910101 |
| Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. | Hepatology (Baltimore, Md.) 19900801 |
| Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid. | Archives of internal medicine 19900701 |
| Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones. | The Quarterly journal of medicine 19900701 |
| Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. | Digestive diseases and sciences 19891201 |
| Gallstone dissolution therapy with ursodiol. Efficacy and safety. | Digestive diseases and sciences 19891201 |
| Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study. | Gastroenterology 19831201 |
| Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration. | Gut 19830701 |
| Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids. | Hepatology (Baltimore, Md.) 19830101 |
| Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid. | Gut 19801201 |